学校法人順天堂　研究者情報データベース:::研究業績詳細:::

HOME　＞　研究業績詳細

研究業績詳細

永原章仁（ナガハラアキヒト）

研究テーマ	消化管学
研究業績（論文）	4.Nagahara A, Watanabe S, Miwa H, Endo K, Hirose M, Sato N. Reduction of gap junction protein connexin 32 in rat atrophic gastric mucosa as an early event in carcinogenesis. J Gastroenterol 31:491-497,1996. 21. Nagahara A, Miwa H, Ogawa K, Kurosawa A, Ohkura R, Iida N, Sato N. Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy. Helicobacter 5:88-93, 2000. 23. Nagahara A, Miwa H, Yamada T, Kurosawa A, Ohkura R, Sato N. 5-day PPI based quadruple therapy regimen is more effective than 7-day PPI based triple therapy regimen for Helicobacter pylori infection. Aliment Pharmacol Ther 15:417-421, 2001. 31. Nagahara A, Miwa H, Kawabe M, Kurosawa A, Asaoka D, Hojo M, Iijima K, Terai T, Ohkusa T, Miyazaki A, Sato N. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen. J Gastroenterol 39:1051-1055, 2004. 35. Nagahara A, Miwa H, Minoo T, Hojo M, Kawabe M, Osada T, Kurosawa A, Asaoka D, Terai T, Ohkusa T, Sato N. Increased esophageal sensitivity to acid and saline in patients with non-erosive gastro-esophageal reflux disease. J Clin Gastroenterol 40:891-895,2006. 43. Nagahara A, Miwa H, Hojo M, Yoshizawa T, Kawabe M, Osada T, Kurosawa A, Ohkusa T, Watanabe S. Efficacy of Lansap combination therapy for eradication of H. pylori. Helicobacter 12:643-4, 2007. 64. Nagahara A , Asaoka D, Hojo M , Oguro M , Shimada Y , Ishikawa D, Osada T, Kawabe M, Yoshizawa T, Otaka M, Watanabe S. Observational comparative trial of the efficacy of PPI versus H2RA for uninvestigated dyspepsia. J Gastroenterol Hepatol 25 Suppl 1: S122-S128,2010.IF:3.452/CI:10 65. Kato J, Nagahara A, Iijima K, Kodani T, Higashihara Y, Yoshimura M, Serizawa N, Osada T, Yoshizawa T, Otaka M, Watanabe S. Phase I study of paclitaxel, cisplatin and 5-fluorouracil combination chemotherapy for unresectable / recurrent gastric cancer. Adv Med Sci. 55:137-42.2010.IF:1.364/CI:3 66. Beppu K, Nagahara A, Terai T, Matsumoto K, Shibuya T, Sakamoto N, Osada T,Kawabe M, Otaka M, Ogihara T, Watanabe S. Clinicopathological characteristics of colorectal cancer less than 10 mm in diameter and invading submucosa and below. JGastroenterol Hepatol 25 Suppl 1:S57-61.2010.IF:3.452/CI:4 67. Fukuo Y, Shibuya T, Fukumura Y, Mizui T, Sai JK, Nagahara A, Tsukada A,Matsumoto T, Suyama M, Watanabe S. Reactive lymphoid hyperplasia of the liver associated with primary biliary cirrhosis. Med Sci Monit. 16:CS81-6.2010.IF:1.585/CI:3 68. Shibuya T, Osada T, Mitomi H, Takeda T, Nomura O, Nakayama H, Hidaka Y, Mori H, Beppu K, Sakamoto N, Nagahara A, Otaka M, Ogihara T, Yao T, Watanabe S. Jejunal capillary hemangioma treated by using double-balloon endoscopy (with video). Gastrointest Endosc. 72:660-1.2010.IF:6.501/CI:5 69. Mori H, Shibuya T, Osada T, Kodani T, Higashihara Y, Serizawa N, Kato J, Nagahara A, Ogihara T, Watanabe S. Response to chemotherapy in a case of gastric adenocarcinoma producing granulocyte colony-stimulating factor. Med Sci Monit. 16:CS119-23.2010.IF:1.585/CI:0 70. Matsumoto K, Nagahara A, Terai T, Ueyama H, Ritsuno H, Mori H, Nakae K, Beppu K, Shibuya T, Sakamoto N, Osada T, Ogihara T, Yao T, Watanabe S. Evaluation of new subclassification of type V(I) pit pattern for determining the depth and type of invasion of colorectal neoplasm. J Gastroenterol. 46:31-8.2011.IF: 4.658/CI:8 71. Nakajima K, Nagahara A, Kurosawa A, Seyama K, Asaoka D, Osada T, Hojo M, Watanabe S. Quit smoking improves gastroesophageal reflux symptoms and quality of life. Health 3:677-83.2011. IF:-/CI:0 72. Miwa H, Inoue K, Ashida K, Kogawa T, Nagahara A, Yoshida S, Tano N, Yamazaki Y, Wada T, Asaoka D, Fujita T, Tanaka J, Shimatani T, Manabe N, Oshima T, Haruma K, Azuma T, Yokoyama T; Japan TREND study group. Randomised clinical trial:efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind , placebo-controlled study. Aliment Pharmacol Ther. 33:323-32.2011.IF:7.286/CI:31 73. Matsumoto K, Nagahara A, Sakamoto N, Suyama M, Konuma H, Morimoto T, Sagawa E, Ueyama H, Takahashi T, Beppu K, Shibuya T, Osada T, Yoshizawa T, Ogihara T, Watanabe S. A new traction device for facilitating endoscopic submucosal dissection (ESD) for early gastric cancer: the "medical ring". Endoscopy. 43 Suppl 2 UCTN:E67-8.2011.IF:5.444/CI:18 74. Beppu K, Osada T, Inoue K, Matsumoto K, Shibuya T, Sakamoto N, Kawabe M, Nagahara A, Ogihara T, Watanabe S. Intestinal involvement in Wegener's granulomatosis diagnosed and followed up by double balloon enteroscopy. Intern Med. 50:219-22.2011.IF:0.815/CI:5 75. Itatsu T, Nagahara A, Hojo M, Miyazaki A, Murai T, Nakajima M, Watanabe S. Use of selective serotonin reuptake inhibitors and upper gastrointestinal disease. Intern Med. 50(7):713-7.2011.IF:0.815/CI:8 76. Oguro M, Koike M, Ueno T, Asaoka D, Mori H, Nagahara A, Uchiyama Y, Watanabe S. Dissociation and dispersion of claudin-3 from the tight junction could be one of the most sensitive indicators of reflux esophagitis in a rat model of the disease. J Gastroenterol. 46:629-38.2011.IF:4.658/CI:23 77. Asaoka D, Nagahara A, Oguro M, Mori H, Nakae K, Izumi Y, Osada T, Hojo M, Otaka M, Watanabe S. Establishment of a reflux esophago-laryngitis model in rats. Dig Dis Sci. 56:1299-308.2011.IF:2.875/CI:4 78. Shibuya T, Ohkusa T, Yokoyama T, Matsumoto K, Beppu K, Sakamoto N, Osada T, Nagahara A, Otaka M, Ogihara T, Watanabe S. Colonic mucosal lesions associated with low-dose aspirin: a case control study. Scand J Gastroenterol. 46:810-7.2011.IF:2.526/CI:3 79. Hojo M, Ohkusa T, Tomeoku H, Koido S, Asaoka D, Nagahara A, Watanabe S. Corticotropin-releasing factor secretion from dendritic cells stimulated by commensal bacteria. World J Gastroenterol. 17:4017-22.2011.IF:3.365/CI:5 80. Kodani T, Osada T, Terai T, Ohkusa T, Shibuya T, Sakamoto N, Beppu K, Kato J, Nagahara A, Watanabe H, Watanabe S. Successful endoscopic mucosal resection of a solitary extramedullary plasmacytoma in the sigmoid colon. Endoscopy. 43 Suppl 2 UCTN:E298-9.2011.IF:5.444/CI:3 81. Beppu K, Osada T, Nagahara A, Matsumoto K, Shibuya T, Sakamoto N, Otaka M, Terai T, Ogihara T, Watanabe S. Relationship between endoscopic findings and clinical severity in ischemic colitis. Intern Med. 50:2263-7.2011.IF:0.815/CI:8 82. Mori H, Sakamoto N, Osada T, Ritsuno H, Hidaka Y, Nakae K, Matsumoto K, Beppu K, Shibuya T, Yoshizawa T, Nagahara A, Otaka M, Ogihara T, Arai F, Watanabe S. The 'Loop Clip' is useful for closing large mucosal defects after colorectal endoscopic submucosal dissection: a preliminary clinical study. Dig Endosc. 23:330-1.2011.IF:3.238/CI:3 83. Ritsuno H, Sakamoto N, Mitomi H, Namihisa A, Mori H, Nakae K, Matsumoto K, Beppu K, Shibuya T, Osada T, Nagahara A, Otaka M, Terai T, Ogihara T, Yao T, Watanabe S. Advanced colorectal cancer with double-hump camel-like appearance. Dig Endosc. 23:329.2011.IF:3.238/CI:0 84. Taniguchi G, Nagahara A, Matsumoto K, Ritsuno H, Sasaki H, Igusa Y, Mori H, Beppu K, Shibuya T, Sakamoto N, Osada T, Kawabe M, Terai T, Ogihara T, Watanabe S. Asymptomatic anisakiasis of the colon incidentally found by colonoscopy. Clinical Journal of Gastroenterology 4:371-373. 2011. IF:-/CI:0 85. Takeda T, Shibuya T, Osada T, Izumi H, Mitomi H, Nomura O, Suzuki S, Mori H,Matsumoto K, Kon K, Abe W, Beppu K, Sakamoto N, Nagahara A, Otaka M, Ogihara T,Yao T, Watanabe S. Metastatic renal cell carcinoma diagnosed by capsule endoscopy and double balloon endoscopy. Med Sci Monit. 17:CS15-7. 2011. IF:1.585/CI:6 86. Hojo M, Takahashi T, Nagahara A, Sasaki H, Oguro M, Asaoka D, Watanabe S. Analysis of brain 5activity during visceral stimulation. J Gastroenterol Hepatol. 27 Suppl 3:49-52.2012.IF:3.452/CI:5 87. Nagahara A, Hojo M, Asaoka D, Sasaki H, Oguro M, Mori H, Matsumoto K, Osada T, Yoshizawa T, Watanabe S. Clinical feature of asymptomatic reflux esophagitis in patients who underwent upper gastrointestinal endoscopy. J Gastroenterol Hepatol. 27 Suppl 3:53-7. 2012.IF:3.452/CI:6 88. Sakurai K, Nagahara A, Inoue K, Akiyama J, Mabe K, Suzuki J, Habu Y, Araki A, Suzuki T, Satoh K, Nagami H, Harada R, Tano N, Kusaka M, Fujioka Y, Fujimura T, Shigeto N, Oumi T, Miwa J, Miwa H, Fujimoto K, Kinoshita Y, Haruma K. Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS). BMC Gastroenterol. 12:42.2012.IF:2.212/CI:13 89. Kodani T, Osada T, Matsumoto K, Kato J, Higashihara Y, Morimoto T, Ogata C, Taniguchi G, Mizui T, Matsumura Y, Yoshizawa T, Nagahara A, Mitomi H, Yao T, Watanabe S. Endoscopic mucosal resection using a cap-fitted panendoscope as a diagnostic procedure in a case of scirrhous gastric carcinoma. Dig Endosc. 24:190. 2012.IF:3.238/CI:1 90. Shibuya T, Mori H, Takeda T, Konishi M, Fukuo Y, Matsumoto K, Beppu K, Sakamoto N, Osada T, Nagahara A, Otaka M, Ogihara T, Watanabe S. The relationship between physical activity level and completion rate of small bowel examination in patients undergoing capsule endoscopy. Intern Med. 2012;51:997-1001. 2012.IF:0.815/CI:8 91. Lee SY, Tomoyoshi S, Haga K, Sasaki H, Ogata C, Nomura O, Fukuo Y, Abe W, Osada T, Nagahara A, Ogihara T, Kamiyama H, Sakamoto K, Watanabe S. Multiple carcinoid tumors of the small intestine preoperatively diagnosed by double-balloon endoscopy. Med Sci Monit. 18:CS109-112. 2012.IF:1.585/CI:4 92. Matsumoto K, Nagahara A, Ueyama H, Konuma H, Morimoto T, Sasaki H, Hayashi T, Shibuya T, Sakamoto N, Osada T, Ogihara T, Yao T, Watanabe S. Development and clinical usability of a new traction device "medical ring" for endoscopic submucosal dissection of early gastric cancer. Surg Endosc.27:3444-51, 2013.IF:3.747/CI:2 93. Asaoka D, Nagahara A, Matsuhisa T, Takahashi S, Tokunaga K, Kawai T, Kawakami K, Suzuki H, Suzuki M, Nishizawa T, Kurihara N, Ito M, Sasaki H, Omata F, Mizuno S, Torii A, Ohkusa T, Mine T, Sakaki N. Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area. Helicobacter.18:468-72, 2013.IF:3.429/CI:12 94. Osada T, Sakamoto N, Ritsuno H, Murakami T, Ueyama H, Shibuya T, Matsumoto K,Nagahara A, Ogihara T, Watanabe S. Process of wound healing of large mucosal defect areas that were sutured by using a loop clip-assisted closure technique after endoscopic submucosal dissection of a colorectal tumor. Gastrointest Endosc. 78:793-8, 2013.IF:6.501/CI:4 95. Ueyama H, Matsumoto K, Nagahara A, Gushima R, Hayashi T, Yao T, Watanabe S. A white opaque substance-positive gastric hyperplastic polyp with dysplasia. World J Gastroenterol. 19:4262-6, 2013.IF:3.365/CI:2 96. Iwakiri R, Tominaga K, Furuta K, Inamori M, Furuta T, Masuyama H, Kanke K, Nagahara A, Haruma K, Kinoshita Y, Higuchi K, Takahashi S, Kusano M, Iwakiri K, Kato M, Hongo M, Hiraishi H, Watanabe S, Miwa H, Naito Y, Fujimoto K, Arakawa T. Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan. Aliment Pharmacol Ther. 38:729-40, 2013.IF:7.286/CI:19 97. Takeda T, Murakami T, Sakamoto N, Goto SP, Ritsuno H, Ueyama H, Mori H, Matsumoto K, Shibuya T, Osada T, Nagahara A, Ogihara T, Watanabe S. Traction device to remove an adenoma in the appendiceal orifice by endoscopic submucosal dissection. Endoscopy. 45 Suppl 2:E239-40, 2013.IF:5.444/CI:3 98. Sasaki H, Nagahara A, Hojo M, Asaoka D, Matsumoto K, Osada T, Watanabe S.Ten-Year Trend of the Cumulative Helicobacter pylori Eradication Rate for the 'Japanese Eradication Strategy'. Digestion. 88:272-278, 2013.IF:2.088/CI:5 99. Hirai M, Matsumoto K, Ueyama H, Fukushima H, Murakami T, Sasaki H, Nagahara A, Yao T, Watanabe S. A case of neuroendocrine tumor G1 with unique histopathological growth progress. World J Gastrointest Endosc. 5:605-9, 2013.IF:-/CI:0 100. Koido S, Ohkusa T, Saito H, Yokoyama T, Shibuya T, Sakamoto N, Uchiyama K, Arakawa H, Osada T, Nagahara A, Watanabe S, Tajiri H. Seasonal variations in the onset of ulcerative colitis in Japan. World J Gastroenterol.19:9063-8, 2013.IF:3.365/CI:2 101. Ueyama H, Matsumoto K, Nagahara A, Hayashi T, Yao T, Watanabe S. Gastric adenocarcinoma of the fundic gland type (chief cell predominant type). Endoscopy. 46:153-7, 2014.IF:5.444/CI:15 102. Nagahara A, Suzuki T, Nagata N, Sugai N, Takeuchi Y, Sakurai K, Miyamoto M, Inoue K, Akiyama J, Mabe K, Konuma I, Kamada T, Haruma K. A multicentre randomised trial to compare the efficacy of omeprazole versus rabeprazole in early symptom relief in patients with reflux esophagitis. J Gastroenterol. 49:1536-47, 2014.IF: 4.658/CI:3 103. Higashihara Y, Kato J, Nagahara A, Izumi K, Konishi M, Kodani T, Serizawa N, Osada T, Watanabe S. Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer. Int J Oncol. 44:662-8, 2014.IF:3.079/CI:5 104. Konishi M, Shibuya T, Mori H, Kurashita E, Takeda T, Nomura O, Fukuo Y, Matsumoto K, Sakamoto N, Osada T, Nagahara A, Ogihara T, Watanabe S. Usefulness of flexible spectral imaging color enhancement for the detection and diagnosis of small intestinal lesions found by capsule endoscopy. Scand J Gastroenterol. 49:501-5, 2014.IF:2.526/CI:7 105. Nagahara A, Hojo M, Asaoka D, Sasaki H, Watanabe S. A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan. Scand J Gastroenterol. 49:409-17, 2014.IF:2.526/CI:8 106. Tominaga K, Kato M, Takeda H, Shimoyama Y, Umegaki E, Iwakiri R, Furuta K, Sakurai K, Odaka T, Kusunoki H, Nagahara A, Iwakiri K, Furuta T, Murakami K, Miwa H, Kinoshita Y, Haruma K, Takahashi S, Watanabe S, Higuchi K, Kusano M, Fujimoto K, Arakawa T; G-PRIDE Study Group. A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study. J Gastroenterol. 49:1392-405, 2014.IF: 4.658/CI:13 107. Izumi K, Osada T, Sakamoto N, Kodani T, Higashihara Y, Ritsuno H, Shibuya T, Nagahara A, Ogihara T, Kikuchi K, Watanabe S. Frequent occurrence of fever in patients who have undergone endoscopic submucosal dissection for colorectal tumor, but bacteremia is not a significant cause. Surg Endosc. 28:2899-904, 2014.IF:3.747/CI:3 108. Ritsuno H, Sakamoto N, Osada T, Goto SP, Murakami T, Ueyama H, Mori H, Matsumoto K, Beppu K, Shibuya T, Nagahara A, Ogihara T, Watanabe S. Prospective clinical trial of traction device-assisted endoscopic submucosal dissection of large superficial colorectal tumors using the S-O clip. Surg Endosc. 28:3143-9, 2014.IF:3.747/CI:11 109. Suyama M, Koike M, Asaoka D, Mori H, Oguro M, Ueno T, Nagahara A, Watanabe S, Uchiyama Y. Increased Immunoreactivity of Cathepsins in the Rat Esophagus under Chronic Acid Reflux Esophagitis. J Histochem Cytochem. 62:645-60, 2014.IF:2.511/CI:1 110. Koido S, Ohkusa T, Nakae K, Yokoyama T, Shibuya T, Sakamoto N, Uchiyama K, Arakawa H, Osada T, Nagahara A, Watanabe S, Tajiri H. Factors associated with incomplete colonoscopy at a Japanese academic hospital. World J Gastroenterol.20:6961-7, 2014.IF:3.365/CI:7 111. Sakata Y, Tominaga K, Kato M, Takeda H, Shimoyama Y, Takeuchi T, Iwakiri R, Furuta K, Sakurai K, Odaka T, Kusunoki H, Nagahara A, Iwakiri K, Furuta T, Murakami K, Miwa H, Kinoshita Y, Haruma K, Takahashi S, Watanabe S, Higuchi K, Fujimoto K, Kusano M, Arakawa T; G-PRIDE study group. Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito. BMC Gastroenterol. 14:116, 2014.IF:2.212/CI:8 112. Asaoka D, Nagahara A, Hojo M, Sasaki H, Shimada Y, Yoshizawa T, Osada T, Watanabe S. The Relationship between H. pylori Infection and Osteoporosis in Japan. Gastroenterol Res Pract. 340765, 2014.IF:1.863/CI:2 113. Goto SP, Sakamoto N, Mitomi H, Murakami T, Ritsuno H, Ueyama H, Matsumoto K, Shibuya T, Osada T, Nagahara A, Ogihara T, Yao T, Watanabe S. Histological Distinction between the Granular and Nongranular Types of Laterally Spreading Tumors of the Colorectum. Gastroenterol Res Pract. 153935, 2014.IF:1.863/CI:0 114. Kumagai E, Shibuya T, Makino M, Murakami T, Takashima S, Ritsuno H, Ueyama H,　Kodani T, Sasaki H, Matsumoto K, Sakamoto N, Osada T, Nagahara A, Ogihara T,　Watanabe S. A Randomized Prospective Study of Bowel Preparation for Colonoscopy　with Low-Dose Sodium Phosphate Tablets versus Polyethylene Glycol Electrolyte　Solution. Gastroenterol Res Pract. 879749, 2014.IF:1.863/CI:0 115. Morinaga M, Osada T, Kon K, Kato J, Konishi M, Shibuya T, Sakamoto N, Nagahara A, Yao T, Fujime M, Watanabe S. Metastatic seminoma in the duodenum: diagnosis with endoscopy followed by successful treatment. Intern Med. 53:2777-81, 2014.IF:0.815/CI:0 116. Hojo M, Nagahara A, Asaoka D, Ueyama H, Shimada Y, Matsumoto K, Watanabe S. Symptoms of Gastro-Esophageal Reflux Disease: A Comparative Study between Elderly and Younger Patients in Japan. Health 6:1700-5, 2014.IF:-/CI:0 117. Kawai T, Takahashi S, Suzuki H, Sasaki H, Nagahara A, Asaoka D, Matsuhisa T, Masaoaka T, Nishizawa T, Suzuki M, Ito M, Kurihara N, Omata F, Mizuno S, Torii A, Kawakami K, Ohkusa T, Tokunaga K, Mine T, Sakaki N. Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group). J Gastroenterol Hepatol. 29 Suppl 4:29-32, 2014.IF:3.452/CI:11 118. Beppu K, Osada T, Sakamoto N, Shibuya T, Matsumoto K, Nagahara A, Terai T, Ogihara T, Watanabe S. Optimal timing for resuming antithrombotic agents and risk factors for delayed bleeding after endoscopic resection of colorectal tumors. Gastroenterol Res Pract. 825179, 2014.IF:1.863/CI:2 119. Shimada Y, Nagahara A, Hojo M, Asaoka D, Sasaki H, Ueyama H, Matsumoto K, Watanabe S. Upper gastrointestinal mucosal injury and symptoms in elderly low-dose aspirin users. Gastroenterol Res Pract. 252963, 2015.IF:1.863/CI:0 120. Nagahara A, Miwa H, Asaoka D, Shimada Y, Sasaki H, Matsumoto K, Osada T, Hojo M, Watanabe S. Pretreatment prediction of symptom response to proton pump inhibitor therapy. J Gastroenterol Hepatol. 30 Suppl 1:25-30, 2015.IF:3.452/CI:0 121. Asaoka D, Nagahara A, Shimada Y, Matsumoto K, Ueyama H, Matsumoto K, Nakagawa Y, Takeda T, Tanaka I, Sasaki H, Osada T, Hojo M, Watanabe S. Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori? Ther Clin Risk Manag. 11:381-91. 2015.IF:2.200/CI:5 122. Murakami T, Yao T, Mitomi H, Morimoto T, Ueyama H, Matsumoto K, Saito T, Osada T, Nagahara A, Watanabe S. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases. Gastric Cancer. 19:498-507, 2016.IF:5.454/CI:3 123. Obayashi N, Ohtsuka Y, Hosoi K, Ikuse T, Jimbo K, Aoyagi Y, Fujii T, Kudo T, Asaoka D, Hojo M, Nagahara A, Watanabe S, Shimizu T. Comparison of Gene Expression Between Pediatric and Adult Gastric Mucosa with Helicobacter pylori Infection. Helicobacter. 21:114-23, 2016.IF:3.429/CI:3 124. Ito T, Nagahara A, Osada T, Kato J, Ueyama H, Saito H, Taniki N, Kanazawa R, Shimizu R, Sai J, Shiina S, Watanabe S. Efficacy of recombinant human soluble thrombomodulin in patients with sepsis and disseminated intravascular coagulation in the gastroenterology field. Biomed Rep. 3:457-460, 2015.IF:-/CI:1 125. Matsumoto K, Nagahara A, Matsumoto K, Akazawa Y, Komori H, Nakagawa Y, Takeda T, Ueyama H, Shimada Y, Asaoka D, Hojo M, Watanabe S. Optimization of Deep Sedation with Spontaneous Respiration for Therapeutic Endoscopy Combining Propofol and Bispectral Index Monitoring. Gastroenterol Res Pract. 282149, 2015.IF:1.863/CI:0 126. Nagahara A, Asaoka D, Hojo M, Sasaki H, Shimada Y, Matsumoto K, Ueyama H, Shibuya T, Sakamoto N, Osada T, Watanabe S. Difference in efficacy of proton pump inhibitor between new-onset and recurrent gastroesophageal reflux disease: Result from a study of on-demand versus continuous maintenance therapy in Japan. Hippokratia. 19:53-6, 2015.IF:0.467/CI:0 127. Sato S, Genda T, Ichida T, Murata A, Tsuzura H, Narita Y, Kanemitsu Y, Ishikawa S, Kikuchi T, Mori M, Hirano K, Iijima K, Wada R, Nagahara A, Watanabe S. Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma. J Gastroenterol Hepatol. 31:1315-22, 2016.IF:3.452/CI:3 128. Asaoka D, Nagahara A, Hojo M, Matsumoto K, Ueyama H, Matsumoto K, Izumi K, Takeda T, Komori H, Akazawa Y, Shimada Y, Osada T, Watanabe S. Efficacy of alfacalcidol and alendronate on lumbar bone mineral density in osteoporotic patients using proton pump inhibitors. Biomed Rep. 5:165-170, 2016.IF:-/CI:0 129. Ueyama H, Yao T, Matsumoto K, Nakagawa Y, Takeda T, Matsumoto K, Nagahara A, Watanabe S. Flat-type primary malignant melanoma of the esophagus. Endosc Int Open. 4:E687-9, 2016. IF:-/CI:0 130. Murata A, Genda T, Ichida T, Amano N, Sato S, Tsuzura H, Sato S, Narita Y, Kanemitsu Y, Shimada Y, Hirano K, Iijima K, Wada R, Nagahara A, Watanabe S. Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication. World J Gastroenterol. 22:7569-78, 2016.IF:3.365/CI:0 131. Matsumoto K, Ueyama H, Matsumoto K, Akazawa Y, Komori H, Takeda T, Murakami T, Asaoka D, Hojo M, Tomita N, Nagahara A, Kajiyama Y, Yao T, Watanabe S. Clinicopathological features of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation. World J Gastroenterol. 22:8203-10, 2016.IF:3.365/CI:1 132. Asaoka D, Nagahara A, Hojo M, Matsumoto K, Ueyama H, Matsumoto K, Izumi K, Takeda T, Komori H, Akazawa Y, Shimada Y, Osada T, Watanabe S. Association of medications for lifestyle-related diseases with reflux esophagitis. Ther Clin Risk Manag. 12:1507-1515, 2016. IF:2.200/CI:0 133. Sato S, Genda T, Ichida T, Amano N, Sato S, Murata A, Tsuzura H, Narita Y, Kanemitsu Y, Hirano K, Shimada Y, Iijima K, Wada R, Nagahara A, Watanabe S. Prediction of Hepatocellular Carcinoma Development after Hepatitis C Virus Eradication Using Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein. Int J Mol Sci. 17. pii: E2143, 2016.IF:3.226/CI:0 134. Konuma H, Matsumoto K, Ueyama H, Komori H, Akazawa Y, Ueyama M, Nakagawa Y, Morimoto T, Takeda T, Matsumoto K, Asaoka D, Hojo M, Nagahara A, Yao T, Miyazaki A, Watanabe S. Procedure Time for Gastric Endoscopic Submucosal Dissection according to Location, considering Both Mucosal Circumferential Incision and Submucosal Dissection. Gastroenterol Res Pract. 9183793, 2016.IF1.863/CI:0 135. Mori M, Genda T, Ichida T, Murata A, Kamei M, Tsuzura H, Sato S, Narita Y, Kanemitsu Y, Ishikawa S, Kikuchi T, Shimada Y, Hirano K, Iijima K, Sugimoto K, Wada R, Nagahara A, Watanabe S. Aldo-keto reductase family 1 member B10 is associated with hepatitis B virus-related hepatocellular carcinoma risk. Hepatol Res. 47:E85-E93, 2017.IF:2.602/CI:0 136. Shibuya T, Nomura O, Kodani T, Murakami T, Fukushima H, Tajima Y, Matsumoto K, Ritsuno H, Ueyama H, Inami Y, Ishikawa D, Matsumoto K, Sakamoto N, Osada T, Nagahara A, Ogihara T, Watanabe S. Continuation of antithrombotic therapy may be associated with a high incidence of colonic post-polypectomy bleeding. Dig Endosc. 29:314-321, 2017.IF:3.238/CI:0 137. Okada E, Ukawa S, Nakamura K, Hirata M, Nagai A, Matsuda K, Ninomiya T, Kiyohara Y, Muto K, Kamatani Y, Yamagata Z, Kubo M, Nakamura Y; BioBank Japan Cooperative Hospital Group, Tamakoshi A. Demographic and lifestyle factors and survival among patients with esophageal and gastric cancer: The Biobank Japan Project (Members of medical institutions cooperating in the BioBank Japan Project who coauthored this paper include Rai Shimoyama, Shinichiro Makimoto, Hiromasa Harada and Tomoaki Fujikawa (Tokushukai Hospitals); Shiro Minami, Eiji Uchida and Masao Miyashita (Nippon Medical School); Yoshiaki Kajiyama, Natsumi Tomita and Akihito Nagahara (Juntendo University); Satoshi Asai, Mitsuhiko Moriyama and Yasuo Takahashi (Nihon University); Tomoaki Fujioka and Wataru Obara (Iwate Medical University); Seijiro Mori and Hideki Ito (Tokyo Metropolitan Institute of Gerontology); Satoshi Nagayama and Yoshio Miki (The Cancer Institute Hospital of JFCR); Akihide Masumoto and Akira Yamada (Aso Iizuka Hospital); Yasuko Nishizawa and Ken Kodama (Osaka Medical Center for Cancer and Cardiovascular Diseases); Hiromitsu Ban and Satoshi Murata (Shiga University of Medical Science); Yukihiro Koretsune and Motohiro Hirao (National Hospital Organization, Osaka National Hospital); and Hideo Ogata (Fukujuji Hospital).). J Epidemiol. 27(3S):S29-S35, 2017.IF:2.447/CI:1 138. Asaoka D, Nagahara A, Hojo M, Matsumoto K, Ueyama H, Matsumoto K, Izumi K, Takeda T, Komori H, Akazawa Y, Shimada Y, Osada T, Watanabe S. Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis, non-erosive reflux disease, and functional dyspepsia. Biomed Rep. 6:175-180, 2017.IF:-/CI:0 139. Hojo M, Nagahara A, Asaoka D, Takeda T, Izumi K, Matsumoto K, Ueyama H, Shimada Y, Matsumoto K, Nojiri S, Watanabe S. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia. Digestion. 96:5-12, 2017. IF:2.088/CI:0 140. Takeda T, Asaoka D, Tajima Y, Matsumoto K, Takeda N, Hiromoto T, Okubo S, Saito H, Aoyama T, Shibuya T, Sakamoto N, Hojo M, Osada T, Nagahara A, Yao T, Watanabe S. Hemorrhagic polyps formed like fundic gland polyps during long-term proton pump inhibitor administration. Clin J Gastroenterol. 2017 Oct;10(5):478-484. Epub 2017 Jun 28. PubMed PMID:　28660530; PubMed Central PMCID: PMC5606985. 141. Hojo M, Nagahara A, Asaoka D, Shimada Y, Sasaki H, Matsumoto K, Tkaedda T, Ueyama H, Matsumoto K, Watanabe S. A Systematic Review of the Effectiveness of Antianxiety and Antidepressive Agents for Functional Dyspepsia. Intern Med. 2017.Dec 1;56(23):3127-3133. doi: 10.2169/internalmedicine.9099-17. Epub 2017 Oct 11. PubMed PMID: 29021437; PubMed Central PMCID: PMC5742382.IF:0.815/CI:0 142. Takeda T, Nagahara A, Ishizuka K, Okubo S, Haga K, Suzuki M, Nakajima A,　Komori H, Akazawa Y, Izumi K, Matsumoto K, Ueyama H, Shimada Y, Matsumoto K,　Asaoka D, Shibuya T, Sakamoto N, Osada T, Hojo M, Nojiri S, Watanabe S. Improved Visibility of Barrett's Esophagus with Linked Color Imaging: Inter- and Intra-Rater Reliability and Quantitative Analysis. Digestion. 2018;97(2):183-194. doi: 10.1159/000485459. Epub 2018 Jan 10. PubMed PMID: 29320766. 143. Kamei M, Shibuya T, Takahashi M, Makino M, Haga K, Nomura O, Murakami T, Ritsuno H, Ueyama H, Kodani T, Ishikawa D, Matsumoto K, Sakamoto N, Osada T, Ogihara T, Watanabe S, Nagahara A. Efficacy and Acceptability of 1 Liter of Polyethylene Glycol with Ascorbic Acid vs. 2 Liters of Polyethylene Glycol Plus Mosapride and Sennoside for Colonoscopy Preparation. Med Sci Monit. 2018 Jan 26;24:523-530. PubMed PMID: 29373569; PubMed Central PMCID: PMC5795919. 144. Tsuruoka N, Iwakiri R, Sakata Y, Fujimoto K, Kamiya T, Joh T, Tokunaga K, Takahashi S, Kinoshita Y, Uchiyama K, Naito Y, Nagahara A, Watanabe T, Chan FKL, Hahm KB, Kachintorn U, Fock KM, Syam AF, Rani AA, Sollano JD, Zhu Q. Questionnaire-Based Survey on Gastrointestinal Bleeding and Management of Antithrombotic Agents during Endoscopy Among Asian Countries. Digestion. 2018;97(1):97-106. doi: 10.1159/000484228. Epub 2018 Feb 2. PubMed PMID: 29402809. 145. Ikuse T, Ohtsuka Y, Obayashi N, Jimbo K, Aoyagi Y, Kudo T, Asaoka D, Hojo M, Nagahara A, Watanabe S, Blanchard TG, Czinn SJ, Shimizu T. Host response genes associated with nodular gastritis in H. pylori infection. Pediatr Int. 2018 Feb 7. doi: 10.1111/ped.13527. [Epub ahead of print] PubMed PMID: 29415337. 146. Tominaga K, Sakata Y, Kusunoki H, Odaka T, Sakurai K, Kawamura O, Nagahara A, Takeuchi T, Fujikawa Y, Oshima T, Kato M, Furuta T, Murakami K, Chiba T, Miwa H, Kinoshita Y, Higuchi K, Kusano M, Iwakiri R, Fujimoto K, Tack JF, Arakawa T. Rikkunshito simultaneously improves dyspepsia correlated with anxiety in patients with functional dyspepsia: A randomized clinical trial (the DREAM study). Neurogastroenterol Motil. 2018 Mar 2. doi: 10.1111/nmo.13319. [Epub ahead of print] PubMed PMID: 29498457. 147. Hiromoto T, Murakami T, Akazawa Y, Sasahara N, Saito T, Sakamoto N, Mitomi H, Nagahara A, Yao T. Immunohistochemical and genetic characteristics of a colorectal mucin-rich variant of traditional serrated adenoma. Histopathology. 2018 May 5. doi: 10.1111/his.13643. [Epub ahead of print] PubMed PMID: 29729192. 148. Tomishima K, Sato S, Amano N, Murata A, Tsuzura H, Sato S, Kanemitsu Y, Shimada Y, Iijima K, Genda T, Wada R, Nagahara A. A case of ischemic gastroduodenal disease in a patient who was receiving hemodialysis treatment that was managed by conservative treatment. Clin J Gastroenterol. 2018 May 8. doi:10.1007/s12328-018-0865-1. [Epub ahead of print] PubMed PMID: 29737481. 149. Akazawa Y, Saito T, Hayashi T, Yanai Y, Tsuyama S, Akaike K, Suehara Y, Takahashi F, Takamochi K, Ueyama H, Murakami T, Watanabe S, Nagahara A, Yao T. Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: emphasis on the relationship with hepatoid adenocarcinoma. Hum Pathol. 2018 Aug;78:79-88. doi: 10.1016/j.humpath.2018.04.022. Epub 2018 May 8. PubMed PMID: 29751042. 150. Hojo M, Asahara T, Nagahara A, Takeda T, Matsumoto K, Ueyama H, Matsumoto K, Asaoka D, Takahashi T, Nomoto K, Yamashiro Y, Watanabe S. Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors. Dig Dis Sci. 2018 May 24. doi: 10.1007/s10620-018-5122-4. [Epub ahead of print] PubMed PMID: 29796911. 151. Akazawa Y, Ueyama H, Yao T, Komori H, Takeda T, Matsumoto K, Matsumoto K, Asaoka D, Hojo M, Watanabe S, Nagahara A. Usefulness of Demarcation of Differentiated-Type Early Gastric Cancers after Helicobacter pylori Eradication by Magnifying Endoscopy with Narrow-Band Imaging. Digestion. 2018 Jun 5;98(3):175-184. doi: 10.1159/000489167. [Epub ahead of print] PubMed PMID:29870997. 152. Takeda T, Matsumoto K, Nagahara A, Komori H, Akazawa Y, Nakagawa Y, Izumi K, Matsumoto K, Ueyama H, Shimada Y, Asaoka D, Hojo M, Yao T, Watanabe S. Effect of Esophageal Endoscopic Submucosal Dissection on Motility and Symptoms: A Prospective Study. Gastroenterol Res Pract. 2018 Jun 3;2018:3735473. doi: 10.1155/2018/3735473. eCollection 2018. PubMed PMID: 29967638; PubMed Central PMCID: PMC6008697. 153.Murakami T, Sakamoto N, Nagahara A. Endoscopic diagnosis of sessile serrated adenoma/polyp with and without dysplasia/carcinoma. World J Gastroenterol. 2018Aug 7;24(29):3250-3259. doi: 10.3748/wjg.v24.i29.3250. Review. PubMed PMID: 30090005; PubMed Central PMCID: PMC6079289. 154.Shibuya T, Haga K, Kamei M, Okahara K, Ito S, Takahashi M, Nomura O, Murakami T, Makino M, Kodani T, Ishikawa D, Sakamoto N, Osada T, Ogihara T, Watanabe S, Nagahara A. Successful remission of ulcerative colitis flare-up during pregnancy with adsorptive granulomonocytapheresis plus tacrolimus. Intest Res. 2018 Jul;16(3):484-488. doi: 10.5217/ir.2018.16.3.484. Epub 2018 Jul 27. PubMed PMID: 30090048; PubMed Central PMCID: PMC6077305. 155.Ishikawa D, Sasaki T, Takahashi M, Kuwahara-Arai K, Haga K, Ito S, Okahara K, Nakajima A, Shibuya T, Osada T, Hiramatsu K, Watanabe S, Nagahara A. The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics. Inflamm Bowel Dis. 2018 Nov 29;24(12):2590-2598. doi: 10.1093/ibd/izy266. PubMed PMID: 30124831. 156.Murakami T, Akazawa Y, Yatagai N, Hiromoto T, Sasahara N, Saito T, Sakamoto N, Nagahara A, Yao T. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study. Diagn Pathol. 2018 Nov 20;13(1):88. doi: 10.1186/s13000-018-0771-3. PubMed PMID: 30458818; PubMed Central PMCID: PMC6247685 157.Takahashi M, Ishikawa D, Sasaki T, Lu YJ, Kuwahara-Arai K, Kamei M, Shibuya T, Osada T, Hiramatsu K, Nagahara A. Faecal freezing preservation period influences colonization ability for faecal microbiota transplantation. J Appl Microbiol. 2018 Nov 29. doi: 10.1111/jam.14167. [Epub ahead of print] PubMed PMID: 30489686. 158.Yamaguchi S, Sasaki K, Kato H, Fukudo S, Iwakiri R, Kamiya T, Motoya S, Murakami K, Nagahara A, Suzuki H, Watanabe T, Takahashi S, Chan FKL, Hahm KB, Kachintorn U, Ming FK, Rani AA, Sollano JD, Zhu Q. Questionnaire-Based Survey on Management of Ulcerative Colitis-Associated Cancer in East Asian Countries. Digestion. 2019;99(1):86-94. doi: 10.1159/000494419. Epub 2018 Dec 14. PubMed PMID: 30554204. 159.Yatagai N, Saito T, Akazawa Y, Hayashi T, Yanai Y, Tsuyama S, Ueyama H, Murakami T, Watanabe S, Nagahara A, Yao T. TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation. Virchows Arch. 2018 Dec 15. doi: 10.1007/s00428-018-2508-9. [Epub ahead of print] PubMed PMID: 30554333. 160.Akazawa Y, Hayashi T, Saito T, Niwa K, Kamiyama H, Sasahara N, Sakamoto K, Nagahara A, Yao T. Histological characteristics of eosinophilic myenteric ganglionitis: an under-recognised cause of chronic intestinal pseudo-obstruction. Virchows Arch. 2019 Jan 4. doi: 10.1007/s00428-018-02513-5. [Epub ahead of print] PubMed PMID: 30607555. 161.Komori H, Ueyama H, Nagahara A, Akazawa Y, Takeda T, Matsumoto K, Matsumoto K, Asaoka D, Hojo M, Yao T, Watanabe S. A prospective randomized trial of a potassium competitive acid blocker vs proton pump inhibitors on the effect of ulcer healing after endoscopic submucosal dissection of gastric neoplasia. J Int Med Res. 2019 Apr;47(4):1441-1452. doi: 10.1177/0300060519828514. Epub 2019 Feb 28. PubMed PMID: 30816056; PubMed Central PMCID: PMC6460617. 162.Yatagai N, Saito T, Akazawa Y, Hayashi T, Yanai Y, Tsuyama S, Murakami T, Ueyama H, Watanabe S, Nagahara A, Yao T. Frequent loss of heterozygosity of SMAD4 locus and prognostic impacts of SMAD4 immunohistochemistry in gastric adenocarcinoma with enteroblastic differentiation. Hum Pathol. 2019 Jun;88:18-26. doi: 10.1016/j.humpath.2019.03.005. Epub 2019 Apr 1. PubMed PMID: 30946932. 163.Asaoka D, Takeda T, Sasaki H, Shimada Y, Matsumoto K, Ueyama H, Matsumoto K, Izumi K, Komori H, Akazawa Y, Osada T, Hojo M, Nagahara A. Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users. Biomed Rep. 2019 May;10(5):277-282. doi: 10.3892/br.2019.1206. Epub 2019 Apr 9. PubMed PMID: 31086661; PubMed Central PMCID: PMC6489533. 164.Murakami T, Sakamoto N, Nagahara A. Clinicopathological features, diagnosis, and treatment of sessile serrated adenoma/polyp with dysplasia/carcinoma. J Gastroenterol Hepatol. 2019 Oct;34(10):1685-1695. doi: 10.1111/jgh.14752. Epub 2019 Jun 30. PMID: 31158302. 165.Takeda T, Asaoka D, Nojiri S, Nishiyama M, Ikeda A, Yatagai N, Ishizuka K, Hiromoto T, Okubo S, Suzuki M, Nakajima A, Nakatsu Y, Komori H, Akazawa Y, Nakagawa Y, Izumi K, Matsumoto K, Ueyama H, Sasaki H, Shimada Y, Matsumoto K, Osada T, Hojo M, Kato M, Nagahara A. Linked Color Imaging and the Kyoto Classification of Gastritis: Evaluation of Visibility and Inter-RaterReliability. Digestion. 2019 Jul 12:1-10. doi: 10.1159/000501534. [Epub ahead of print] PubMed PMID: 31302654. 166.Murakami T, Yao T, Yatagai N, Yamashiro Y, Saito T, Sakamoto N, Nagahara A. Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological study of five cases. Histopathology. 2020 Jan;76(2):325-332. doi: 10.1111/his.13973. Epub 2019 Oct 30. PMID: 31429980. 167.Uchida S, Izawa K, Ando T, Yamada H, Uchida K, Negishi N, Kaitani A, Maehara A, Nagamine M, Kamei A, Takamori A, Maeda K, Nakano N, Shimizu T, Ogawa H, Okumura K, Nagahara A, Watanabe S, Kitaura J. CD300f is a potential therapeutic target for the treatment of food allergy. Allergy. 2020 Feb;75(2):471-474. doi: 10.1111/all.14034. Epub 2019 Oct 2. PMID: 31471969.. 168.Amano N, Ikeda Y, Hayashida S, Takahashi S, Sato S, Murata A, Tsuzura H, Sato S, Shimada Y, Iijima K, Wada R, Nagahara A, Genda T. Prognostic significance of serum tyrosine concentration in patients with primary biliary cholangitis under ursodeoxycholic acid therapy. Hepatol Res. 2020Feb;50(2):214-223. doi: 10.1111/hepr.13434. Epub 2020 Jan 5. PMID: 31652380. 169.Shibuya T, Nomura O, Nomura K, Okahara K, Haga K, Ishikawa D, Sakamoto N, Ogihara T, Osada T, Nagahara A. Effectiveness of Cytapheresis for Ulcerative Colitis in Special Situations: Delayed Onset of Optimum Efficacy in Elderly Patients. Digestion. 2020;101(1):46-52. doi: 10.1159/000504091. Epub 2019 Nov 13. PMID: 31722366. 170.Hojo M, Nagahara A, Hahm KB, Iwakiri R, Watanabe T, Rani AA, Zhu Q, Chan FKL, Sollano JD, Kamiya T, Yamaguchi S, Motoya S, Fock KM, Fukudo S, Kachintorn U, Suzuki H, Murakami K; The International Gastroenterology Consensus Symposium Study Group. Management of Gastroesophageal Reflux Disease in Asian Countries: Results of a Questionnaire Survey. Digestion. 2020;101(1):66-79. doi: 10.1159/000504749. Epub 2019 Dec 4. PMID: 31801133. 171.Sato S, Sato S, Tsuzura H, Ikeda Y, Hayashida S, Takahashi S, Amano N, Murata A, Shimada Y, Iijima K, Nagahara A, Genda T. Elevated serum procalcitonin levels and their association with the prognosis of patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2019 Dec 16. doi: 10.1097/MEG.0000000000001644. Epub ahead of print. PMID: 31851098. 172.Shibuya T, Nomura K, Okahara K, Haga K, Nomura O, Murakami T, Uchida S, Kodani T, Ishikawa D, Sakamoto N, Ogihara T, Osada T, Nagahara A. Budesonide Foam for Ulcerative Colitis Patients Experiencing Inadequate Response to Biological Therapy. Med Sci Monit. 2019 Dec 22;25:9855-9863. doi: 10.12659/MSM.918562. PMID: 31865359; PMCID: PMC6939661. 173.Matsumoto K, Konuma H, Ueyama H, Komori H, Akazawa Y, Ueyama M, Takeda T, Matsumoto K, Asaoka D, Hojo M, Yao T, Nagahara A. Multibending scope use for reduction of perforation risks in endoscopic submucosal dissection. Minim Invasive Ther Allied Technol. 2020 Feb 28:1-9. doi: 10.1080/13645706.2019.1688352. Epub ahead of print. PMID: 32108547. 174.Okubo H, Ando H, Ishizuka K, Kitagawa R, Okubo S, Saito H, Kokubu S, Miyazaki A, Ikejima K, Shiina S, Nagahara A. Carnitine insufficiency is associated with fatigue during lenvatinib treatment in patients with hepatocellular carcinoma. PLoS One. 2020 Mar 3;15(3):e0229772. doi: 10.1371/journal.pone.0229772. PMID: 32126131; PMCID: PMC7053710. 175.Nakajima A, Habu S, Kasai M, Okumura K, Ishikawa D, Shibuya T, Kobayashi O, Osada T, Ohkusa T, Watanabe S, Nagahara A. Impact of maternal dietary gut microbial metabolites on an offspring's systemic immune response in mouse models. Biosci Microbiota Food Health. 2020;39(2):33-38. doi: 10.12938/bmfh.19-013. Epub 2020 Jan 25. PMID: 32328398; PMCID: PMC7162694. 176.Nakajima A, Sasaki T, Itoh K, Kitahara T, Takema Y, Hiramatsu K, Ishikawa D, Shibuya T, Kobayashi O, Osada T, Watanabe S, Nagahara A. A soluble fiber diet increases <i>Bacteroides fragilis</i> group and IgA production in the gut. Appl Environ Microbiol. 2020 Apr 24:AEM.00405-20. doi: 10.1128/AEM.00405-20. Epub ahead of print. PMID: 32332136. 177. Okahara K, Ishikawa D, Nomura K, Ito S, Haga K, Takahashi M, Shibuya T, Osada T, Nagahara A. Matching between Donors and Ulcerative Colitis Patients Is Important for Long-Term Maintenance after Fecal Microbiota Transplantation. J Clin Med. 2020 May 31;9(6):1650. doi: 10.3390/jcm9061650. PMID: 32486476; PMCID: PMC7355579. 178. Akazawa Y, Ueyama H, Tsuyama S, Ikeda A, Yatagai N, Komori H, Takeda T, Matsumoto K, Matsumoto K, Hashimoto T, Tomita N, Kajiyama Y, Kato M, Yao T, Nagahara A. Endoscopic and Clinicopathological Features of Superficial Non- Ampullary Duodenal Tumor Based on the Mucin Phenotypes. Digestion. 2020 Jun 9:1-8. doi: 10.1159/000508040. Epub ahead of print. PMID: 32516774. 179. Haga K, Shibuya T, Nomura K, Okahara K, Nomura O, Ishikawa D, Sakamoto N, Osada T, Nagahara A. Effectiveness and Nephrotoxicity of Long-Term Tacrolimus Administration in Patients with Ulcerative Colitis. J Clin Med. 2020 Jun 7;9(6):1771. doi: 10.3390/jcm9061771. PMID: 32517388; PMCID: PMC7355962. 180. Asaoka D, Takeda T, Inami Y, Abe D, Shimada Y, Matsumoto K, Ueyama H, Matsumoto K, Komori H, Akazawa Y, Osada T, Hojo M, Nagahara A. The Association between Frailty and Abdominal Symptoms: A Hospital-based Cross-sectional Study. Intern Med. 2020;59(14):1677-1685. doi: 10.2169/internalmedicine.4399-19. Epub 2020 Jul 15. PMID: 32669514. 181. Ueyama H, Kato Y, Akazawa Y, Yatagai N, Komori H, Takeda T, Matsumoto K, Ueda K, Matsumoto K, Hojo M, Yao T, Nagahara A, Tada T. Application of artificial intelligence using a convolutional neural network for diagnosis of early gastric cancer based on magnifying endoscopy with narrow-band imaging. J Gastroenterol Hepatol. 2021 Feb;36(2):482-489. doi: 10.1111/jgh.15190. Epub 2020 Jul 28. PMID: 32681536; PMCID: PMC7984440. 182. Shibuya T, Haga K, Saeki M, Haraikawa M, Tsuchihashi H, Okahara K, Nomura O, Fukushima H, Murakami T, Ishikawa D, Ikeda S, Nagahara A. Pyoderma gangrenosum in an ulcerative colitis patient during treatment with vedolizumab responded favorably to adsorptive granulocyte and monocyte apheresis. J Clin Apher. 2020 Sep;35(5):488-492. doi: 10.1002/jca.21821. Epub 2020 Aug 7. PMID: 32767842. 183. Hayashida S, Sato S, Shimada Y, Tsuzura H, Ikeda Y, Takahashi S, Sato S, Amano N, Murata A, Nagahara A, Genda T. Eosinophilic Gastroenteritis in an Ulcerative Colitis Patient During Treatment with Tumor Necrosis Factor-alpha Antagonist. Intern Med. 2020;59(16):1977-1981. doi: 10.2169/internalmedicine.4554-20. Epub 2020 Aug 15. PMID: 32801271; PMCID: PMC7492116. 184. Abe D, Takeda T, Ueyama H, Yao T, Nagahara A. Microperforation due to segmental absence of intestinal musculature during endoscopic submucosal dissection for early esophageal cancer: a case study. VideoGIE. 2020 Jul 5;5(8):339-341. doi: 10.1016/j.vgie.2020.04.002. PMID: 32817923; PMCID: PMC7426616. 185. Murakami T, Sakamoto N, Fukushima H, Shibuya T, Yao T, Nagahara A. Usefulness of the Japan narrow-band imaging expert team classification system for the diagnosis of sessile serrated lesion with dysplasia/carcinoma. Surg Endosc. 2021 Aug;35(8):4528-4538. doi: 10.1007/s00464-020-07967-w. Epub 2020 Sep 9. PMID: 32909209.. 186. Matsumoto K, Ueyama H, Yao T, Abe D, Oki S, Suzuki N, Ikeda A, Yatagai N, Akazawa Y, Komori H, Takeda T, Matsumoto K, Hojo M, Nagahara A. Diagnostic limitations of magnifying endoscopy with narrow-band imaging in early gastric cancer. Endosc Int Open. 2020 Oct;8(10):E1233-E1242. doi: 10.1055/a-1220-6389. Epub 2020 Sep 21. PMID: 33015324; PMCID: PMC7505700. 187. Murakami T, Nagahara A, Yao T. Rare case of colorectal traditional serrated adenoma mimicking a subepithelial lesion. Dig Endosc. 2021 Jan;33(1):208. doi: 10.1111/den.13872. Epub 2020 Nov 20. PMID: 33058274. 188. Takeda T, Asaoka D, Abe D, Suzuki M, Nakagawa Y, Sasaki H, Inami Y, Ikemura M, Utsunomiya H, Oki S, Suzuki N, Ikeda A, Yatagai N, Komori H, Akazawa Y, Matsumoto K, Ueda K, Ueyama H, Shimada Y, Matsumoto K, Hojo M, Osada T, Nojiri S, Nagahara A. Linked color imaging improves visibility of reflux esophagitis. BMC Gastroenterol. 2020 Oct 27;20(1):356. doi: 10.1186/s12876-020-01511-9. PMID: 33109095; PMCID: PMC7590454. 189. Asaoka D, Takeda T, Inami Y, Abe D, Shimada Y, Matsumoto K, Ueyama H, Matsumoto K, Komori H, Akazawa Y, Osada T, Hojo M, Nagahara A. Association between the severity of constipation and sarcopenia in elderly adults: A single-center university hospital-based, cross-sectional study. Biomed Rep. 2021 Jan;14(1):2. doi: 10.3892/br.2020.1378. Epub 2020 Oct 22. PMID: 33235719; PMCID: PMC7678610. 190. Hojo M, Asaoka D, Takeda T, Shimada Y, Matsumoto K, Matsumoto K, Yatagai N, Akazawa Y, Ueda K, Ueyama H, Nagahara A. Randomized controlled study on the effects of triple therapy including vonoprazan or rabeprazole for the second-line treatment of <i>Helicobacter pylori</i> infection. Therap Adv Gastroenterol. 2020 Nov 11;13:1756284820966247. doi: 10.1177/1756284820966247. PMID: 33240391; PMCID: PMC7675913. 191. Ogiwara S, Furihata M, Inami Y, Okawa H, Nomoto Y, Kitamura T, Osada T, Nagahara A. Does Endoscopic Retrograde Cholangiopancreatography Carry Higher Risk for Patients 90 Years and Older? A Single-Institution Retrospective Study. Med Sci Monit. 2020 Dec 7;26:e928033. doi: 10.12659/MSM.928033. PMID: 33281183; PMCID: PMC7731116. 192. Yatagai N, Ueyama H, Ikemura M, Uchida R, Utsunomiya H, Abe D, Oki S, Suzuki N, Ikeda A, Akazawa Y, Komori H, Takeda T, Matsumoto K, Ueda K, Matsumoto K, Asaoka D, Hojo M, Tsuyama S, Hayashi T, Yao T, Nagahara A. Clinicopathological and Endoscopic Features of Raspberry-Shaped Gastric Cancer in Helicobacter pylori-Uninfected Patients. Digestion. 2020 Dec 15:1-8. doi: 10.1159/000511907. Epub ahead of print. PMID: 33321493. 193. Kamiya T, Osaga S, Kubota E, Fukudo S, Motoya S, Murakami K, Nagahara A, Shiotani A, Sugimoto M, Suzuki H, Watanabe T, Yamaguchi S, Chan FKL, Hahm KB, Fock KM, Zhu Q; International Gastroenterology Consensus Symposium Study Group. Questionnaire-Based Survey on Epidemiology of Functional Gastrointestinal Disorders and Current Status of Gastrointestinal Motility Testing in Asian Countries. Digestion. 2020 Dec 16;102(1):73-89. doi: 10.1159/000513292. Epub ahead of print. PMID: 33326975. 194. Matsumoto K, Sakamoto N, Murakami T, Yatagai N, Tsuyama S, Fukushima H, Ueyama H, Shibuya T, Yao T, Nagahara A. Long-term relapse-free treatment with endoscopic submucosal dissection combined with magnifying narrow-band imaging for a pregnant patient with flat-type condyloma acuminatum: a case report. Clin J Gastroenterol. 2021 Apr;14(2):439-445. doi: 10.1007/s12328-020-01288-0. Epub 2021 Jan 4. PMID: 33394332. 195. Takasaki Y, Ishii S, Shibuya T, Fujisawa T, Ushio M, Takahashi S, Ito K, Yamagata W, Suzuki A, Okahara K, Okawa Y, Ochiai K, Tomishima K, Nomura O, Haga K, Saito H, Nagahara A, Isayama H. Endoscopic ultrasound-guided antegrade procedures for managing bile duct stones in patients with surgically altered anatomy: Comparison with double-balloon enteroscopy-assisted endoscopic retrograde cholangiography (with video). Dig Endosc. 2021 Nov;33(7):1179-1187. doi: 10.1111/den.13927. Epub 2021 Feb 9. PMID: 33421211. 196. Ueyama H, Murakami T, Matsumoto K, Sakamoto N, Osada T, Yao T, Nagahara A.　Modified attachment method using S-O clip and multibending scope for gastric ESD　at the greater curvature of the fundus. Endosc Int Open. 2021　Feb;9(2):E195-E196. doi: 10.1055/a-1315-0293. Epub 2021 Jan 25. PMID: 33532558; PMCID: PMC7834921. 197. Ueyama H, Yatagai N, Ikeda A, Akazawa Y, Komori H, Takeda T, Matsumoto K, Ueda K, Matsumoto K, Asaoka D, Hojo M, Yao T, Nagahara A. Dynamic diagnosis of early gastric cancer with microvascular blood flow rate using magnifying endoscopy (with video): A pilot study. J Gastroenterol Hepatol. 2021 Jul;36(7):1927-1934. doi: 10.1111/jgh.15425. Epub 2021 Feb 22. PMID: 33533505; PMCID: PMC8359341. 198. Fukuo Y, Shibuya T, Ashizawa K, Ito K, Saeki M, Fukushima H, Takahashi M, Nomura K, Okahara K, Haga K, Akazawa Y, Nomura O, Ogura K, Okubo H, Nagahara A. Plasmablastic Lymphoma of the Small Intestine in an HIV- and EBV-negative Patient. Intern Med. 2021 Sep 15;60(18):2947-2952. doi: 10.2169/internalmedicine.6837-20. Epub 2021 Mar 29. PMID: 33776007; PMCID: PMC8502670. 199. Nomura K, Ishikawa D, Okahara K, Ito S, Haga K, Takahashi M, Arakawa A, Shibuya T, Osada T, Kuwahara-Arai K, Kirikae T, Nagahara A. Bacteroidetes Species Are Correlated with Disease Activity in Ulcerative Colitis. J Clin Med. 2021 Apr 17;10(8):1749. doi: 10.3390/jcm10081749. PMID: 33920646; PMCID: PMC8073534. 200. Haraikawa M, Kudo H, Shibuya T, Kogure Y, Takase M, Inage H, Yokota T, Htun H, Tagaya E, Fan R, Houshito H, Taniguchi G, Sakamoto K, Nagahara A. Efficacy of CO₂ Infusion for Preoperative Computed Tomographic Angiography with Computed Tomographic Colonography. Med Sci Monit. 2021 May 16;27:e931055. doi: 10.12659/MSM.931055. PMID: 33993185; PMCID: PMC8135977. 201. Tomishima K, Ishii S, Fujisawa T, Ikemura M, Ushio M, Takahashi S, Yamagata W, Takasaki Y, Suzuki A, Ito K, Haga K, Ochiai K, Nomura O, Saito H, Shibuya T, Nagahara A, Isayama H. Evaluation of the Feasibility and Effectiveness of Placement of Fully Covered Self-Expandable Metallic Stents via Various Insertion Routes for Benign Biliary Strictures. J Clin Med. 2021 May 28;10(11):2397. doi: 10.3390/jcm10112397. PMID: 34071678; PMCID: PMC8198386. 202. Tomishima K, Ishii S, Fujisawa T, Yatagai N, Kabemura D, Sato S, Amano N, Murata A, Tsuzura H, Sato S, Matsumoto K, Shimada Y, Genda T, Nagahara A, Isayama H. Does restricting fluid volume impact post-ERCP pancreatitis in patient with heart disease? Saudi J Gastroenterol. 2021 Nov-Dec;27(6):355-360.doi: 10.4103/sjg.sjg_693_20. PMID: 34213425; PMCID: PMC8656333. 203. Shibuya T, Nomura O, Nagahara A. Safety and Efficacy of Ustekinumab for Ulcerative Colitis in a Liver Transplant Patient. Inflamm Bowel Dis. 2021 Nov 15;27(12):e150-e151. doi: 10.1093/ibd/izab169. PMID: 34255040. 204. Ueyama H, Yao T, Akazawa Y, Hayashi T, Kurahara K, Oshiro Y, Yamada M, Oda I, Fujioka S, Kusumoto C, Fukuda M, Uchita K, Kadota T, Oono Y, Okamoto K, Murakami K, Matsuo Y, Kato M, Maehata T, Yahagi N, Yasuhara Y, Yada T, Uraushihara K, Yamane T, Matsuo T, Ito M, Maruyama Y, Osako A, Ono S, Kato M, Yagi K, Hashimoto T, Tomita N, Tsuyama S, Saito T, Matsumoto K, Matsumoto K, Watanabe S, Uemura N, Chiba T, Nagahara A. Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type. J Gastroenterol. 2021 Sep;56(9):814-828. doi: 10.1007/s00535-021-01813-z. Epub 2021 Jul 15. PMID: 34268625; PMCID: PMC8370942. 205. Fukushima H, Sakamoto N, Shibuya T, Haga K, Nomura O, Murakami T, Ueyama H, Ishikawa D, Hojo M, Nagahara A. A Comparative Study of Early Mucosal Healing Following Hot Polypectomy and Cold Polypectomy. Med Sci Monit. 2021 Aug 25;27:e933043. doi: 10.12659/MSM.933043. PMID: 34432770; PMCID: PMC8404476. 206. Tomishima K, Ishii S, Fujisawa T, Ikemura M, Ota H, Kabemura D, Ushio M, Fukuma T, Takahashi S, Yamagata W, Takasaki Y, Suzuki A, Ito K, Saito H, Nagahara A, Isayama H. Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer. Cancers (Basel). 2021 Aug 22;13(16):4224. doi: 10.3390/cancers13164224. PMID: 34439377; PMCID: PMC8391823. 207. Yasutomi Y, Chiba A, Haga K, Murayama G, Makiyama A, Kuga T, Watanabe M, Okamoto R, Nagahara A, Nagaishi T, Miyake S. Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel Disease. Cell Mol Gastroenterol Hepatol. 2022;13(1):81-93. doi: 10.1016/j.jcmgh.2021.08.018. Epub 2021 Aug 28. PMID: 34461283; PMCID: PMC8593615. 208. Takeda T, Ueyama H, Fu KI, Murata S, Nagahara A. Minute gastric adenocarcinoma of the fundic-gland type with submucosal invasion. Endoscopy. 2021 Sep 27. doi: 10.1055/a-1625-5865. Epub ahead of print. PMID: 34571564. 209. Ikemura M, Tomishima K, Ushio M, Takahashi S, Yamagata W, Takasaki Y, Suzuki A, Ito K, Ochiai K, Ishii S, Saito H, Fujisawa T, Nagahara A, Isayama H. Impact of the Coronavirus Disease-2019 Pandemic on Pancreaticobiliary Disease Detection and Treatment. J Clin Med. 2021 Sep 16;10(18):4177. doi: 10.3390/jcm10184177. PMID: 34575288; PMCID: PMC8470255. 210. Fukushima H, Murakami T, Suzuki N, Shibuya T, Yao T, Nagahara A. Rare case of advanced rectal cancer with multiple liver and bone metastases presenting with McKittrick-Wheelock syndrome. JGH Open. 2021 Aug 11;5(9):1103-1105. doi: 10.1002/jgh3.12635. PMID: 34584983; PMCID: PMC8454474. 211. Haga K, Shibuya T, Nomura K, Haraikawa M, Nomura O, Nagahara A. Jejunostomy tube removed after pancreaticoduodenectomy using single-balloon endoscopy. Endoscopy. 2021 Oct 1. doi: 10.1055/a-1630-6122. Epub ahead of print. PMID: 34598284. 212. Hojo M, Nagahara A, Kudo T, Takeda T, Ikuse T, Matsumoto K, Ueda K, Ueyama　H, Matsumoto K, Asaoka D, Shimizu T. Endoscopic findings of <i>Helicobacter pylori</i> gastritis in children and young adults based on the Kyoto classification of gastritis and age-associated changes. JGH Open. 2021 Aug 27;5(10):1197-1202. doi: 10.1002/jgh3.12652. PMID: 34622008; PMCID: PMC8485397. 213. Maruyama T, Murakami T, Akazawa Y, Shibuya T, Nagahara A. A case of improved visibility with gel immersion in the presence of ongoing bleeding during colorectal endoscopic submucosal dissection. VideoGIE. 2021 Jul 23;6(10):478-480. doi: 10.1016/j.vgie.2021.06.009. PMID: 34667916; PMCID: PMC8504151. 214. Fukushima H, Shibuya T, Awatsu T, Kurosawa T, Haga K, Murakami T, Serizawa N, Mori A, Hojo M, Yao T, Hattori N, Nagahara A. CV2/CRMP5-antibody-related Paraneoplastic Neurologic Syndrome Associated with Gastrointestinal Stromal Tumor. Intern Med. 2021 Oct 19. doi: 10.2169/internalmedicine.8425-21. Epub ahead of print. PMID: 34670904. 215. Otani K, Watanabe T, Higashimori A, Suzuki H, Kamiya T, Shiotani A, Sugimoto M, Nagahara A, Fukudo S, Motoya S, Yamaguchi S, Zhu Q, Chan FKL, Hahm KB, Tablante MC, Prachayakul V, Abdullah M, Ang TL, Murakami K; International Gastrointestinal Consensus Symposium Study Group. A Questionnaire-Based Survey on the Impact of the COVID-19 Pandemic on Gastrointestinal Endoscopy in Asia. Digestion. 2022;103(1):7-21. doi: 10.1159/000520287. Epub 2021 Nov 10. PMID: 34758472; PMCID: PMC8678234. 216. Kamba E, Murakami T, Nagahara A. Complete disappearance of a large pedunculated polyp. Dig Endosc. 2021 Nov 22. doi: 10.1111/den.14198. Epub ahead of print. PMID: 34807479. 217. Ueyama H, Akazawa Y, Fujisawa T, Isayama H, Nagahara A. A novel endoscopic shield: a barrier device to minimize virus transmission during endoscopy. Endoscopy. 2021 Dec 15. doi: 10.1055/a-1695-3080. Epub ahead of print. PMID: 34911117. 218. Hojo M, Ueda K, Takeda T, Akazawa Y, Ueyama H, Shimada Y, Asaoka D, Nagahara A. The relationship between <i>Helicobacter pylori</i> infection and reflux esophagitis and the long-term effects of eradication of <i>Helicobacter pylori</i> on reflux esophagitis. Therap Adv Gastroenterol. 2021 Dec 9;14:17562848211059942. doi: 10.1177/17562848211059942. PMID: 34917172; PMCID: PMC8669870. 219. Okubo H, Ando H, Ishizuka K, Morishige JI, Ikejima K, Shiina S, Nagahara A. Impact of genetic polymorphisms on the pharmacokinetics and pharmacodynamics of lenvatinib in patients with hepatocellular carcinoma. J Pharmacol Sci. 2022 Jan;148(1):6-13. doi: 10.1016/j.jphs.2021.08.011. Epub 2021 Sep 1. PMID: 34924131. 220. Okubo H, Ando H, Nakadera E, Ikejima K, Shiina S, Nagahara A. Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis. Nutrients. 2021 Dec 10;13(12):4428. doi: 10.3390/nu13124428. PMID: 34959980; PMCID: PMC8705344. 221. Nakajima A, Shibuya T, Sasaki T, Lu YJ, Ishikawa D, Haga K, Takahashi M, Kaga N, Osada T, Sato N, Nagahara A. Nicotine Oral Administration Attenuates DSS-Induced Colitis Through Upregulation of Indole in the Distal Colon and Rectum in Mice. Front Med (Lausanne). 2021 Dec 13;8:789037. doi: 10.3389/fmed.2021.789037. PMID: 34966763; PMCID: PMC8710606. 222. Hojo M, Asaoka D, Shimada Y, Nojiri S, Nagahara A. Strategies for discontinuation of proton pump inhibitors (PPIs) in patients with long-term PPI administration: a randomized controlled trial. BMC Gastroenterol. 2022 Jan 15;22(1):21. doi: 10.1186/s12876-021-02086-9. PMID: 35033011; PMCID: PMC8760744. 223. Hagiwara T, Sugimoto K, Momose H, Irie T, Honjo K, Okazawa YU, Kawai M, Kawano S, Munakata S, Takahashi M, Kojima Y, Serizawa N, Nagahara A, Hoffman RM, Brock MV, Sakamoto K. CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal Cancer. Anticancer Res. 2022 Feb;42(2):697-707. doi: 10.21873/anticanres.15528. PMID: 35093868. 224. Zhang X, Ishikawa D, Nomura K, Fukuda N, Haraikawa M, Haga K, Shibuya T, Mita T, Nagahara A. Donor Screening Revisions of Fecal Microbiota Transplantation in Patients with Ulcerative Colitis. J Clin Med. 2022 Feb 17;11(4):1055. doi: 10.3390/jcm11041055. PMID: 35207328; PMCID: PMC8879222. 225. Shibuya T, Nomura O, Nomura K, Haraikawa M, Haga K, Ishikawa D, Osada T, Yamaji K, Ikeda S, Nagahara A. Efficacy of cytapheresis for induction therapy and extra-intestinal skin manifestations of ulcerative colitis. Ther Apher Dial. 2022 Mar 5. doi: 10.1111/1744-9987.13823. Epub ahead of print. PMID: 35247233 226. Fujisawa T, Fukuda H, Sakamoto N, Hojo M, Tomishima K, Ishii S, Yokokawa H, Saita M, Naito T, Nagahara A, Watanabe S, Isayama H. Relief Effect of Carbon Dioxide Insufflation in Transnasal Endoscopy for Health Checks-A Prospective, Double-Blind, Case-Control Trial. J Clin Med. 2022 Feb 24;11(5):1231. doi: 10.3390/jcm11051231. PMID: 35268322; PMCID: PMC8911034. 227. Ishikawa D, Zhang X, Nomura K, Seki N, Haraikawa M, Haga K, Shibuya T, Kim YG, Nagahara A. A Randomized Placebo-Controlled Trial of Combination Therapy With Post-triple-antibiotic-therapy Fecal Microbiota Transplantation and Alginate for Ulcerative Colitis: Protocol. Front Med (Lausanne). 2022 Feb 22;9:779205. doi: 10.3389/fmed.2022.779205. PMID: 35273972; PMCID: PMC8902497. 228. Okano S, Yao T, Nomura O, Nagahara A, Hagiwara T, Sugimoto K, Takahashi M, Sakamoto K. Enterocolic Lymphocytic Phlebitis Treated Preoperatively with Biologics and Immunosuppressive Agents. Case Rep Pathol. 2022 Mar 7;2022:5120607. doi: 10.1155/2022/5120607. PMID: 35295675; PMCID: PMC8920688. 229. Kurosawa T, Murakami T, Yamashiro Y, Terukina H, Hayashi T, Saito T, Nojiri S, Sakamoto K, Nagahara A, Yao T. Mucin phenotypes and clinicopathological features of colorectal adenocarcinomas: Correlation with colorectal adenocarcinoma with enteroblastic differentiation. Pathol Res Pract. 2022 Apr;232:153840. doi: 10.1016/j.prp.2022.153840. Epub 2022 Mar 10. PMID: 35303523. 230. Murakami T, Kurosawa T, Fukushima H, Shibuya T, Yao T, Nagahara A. Sessile serrated lesions: Clinicopathological characteristics, endoscopic diagnosis, and management. Dig Endosc. 2022 Mar 29. doi: 10.1111/den.14273. Epub ahead of print. PMID: 35352394. 231. Hakoda A, Takeuchi T, Kojima Y, Fujiwara Y, Nagami Y, Naito Y, Fukuda S, Koike T, Sugimoto M, Hamada K, Kobara H, Yoshida N, Inaba T, Nagahara A, Koizumi E, Murakami K, Furuta T, Ogasawara N, Isomoto H, Shibagaki K, Kataoka H, Suzuki H, Higuchi K. Risk factors and prediction of bleeding after gastric endoscopic submucosal dissection in patients on antithrombotic therapy: newly developed bleeding prediction application software, SAMURAI model. J Clin Biochem Nutr. 2022 Mar;70(2):189-196. doi: 10.3164/jcbn.21-136. Epub 2021 Dec 3. PMID: 35400818; PMCID: PMC8921730. 232. Murakami T, Yao T, Nagahara A. A rare case of early colonic cancer showing diverticulum-like morphology. Dig Endosc. 2022 Apr 12. doi: 10.1111/den.14326. Epub ahead of print. PMID: 35411568. 233. Okubo H, Atsukawa M, Okubo T, Ando H, Nakadera E, Ikejima K, Nagahara A. Gadoxetic acid-enhanced magnetic resonance imaging predicts hyperbilirubinemia induced by glecaprevir during hepatitis C virus treatment. Sci Rep. 2022 May 12;12(1):7847. doi: 10.1038/s41598-022-11707-6. PMID: 35552472; PMCID: PMC9098462. 234. Taniguchi G, Kajino K, Momose S, Saeki H, Yue L, Ohtsuji N, Abe M, Shibuya T, Orimo A, Nagahara A, Watanabe S, Hino O. The Inhibitory Effects of Anti-ERC/Mesothelin Antibody 22A31 on Colorectal Adenocarcinoma Cells, within a Mouse Xenograft Model. Cancers (Basel). 2022 Apr 28;14(9):2198. doi: 10.3390/cancers14092198. PMID: 35565327.

研究テーマ

消化管学

研究業績（論文）

4.Nagahara A, Watanabe S, Miwa H, Endo K, Hirose M, Sato N. Reduction of gap junction protein connexin 32 in rat atrophic gastric mucosa as an early event in carcinogenesis. J Gastroenterol 31:491-497,1996.
21. Nagahara A, Miwa H, Ogawa K, Kurosawa A, Ohkura R, Iida N, Sato N. Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy. Helicobacter 5:88-93, 2000.
23. Nagahara A, Miwa H, Yamada T, Kurosawa A, Ohkura R, Sato N. 5-day PPI based quadruple therapy regimen is more effective than 7-day PPI based triple therapy regimen for Helicobacter pylori infection. Aliment Pharmacol Ther 15:417-421, 2001.
31. Nagahara A, Miwa H, Kawabe M, Kurosawa A, Asaoka D, Hojo M, Iijima K, Terai T, Ohkusa T, Miyazaki A, Sato N. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen. J Gastroenterol 39:1051-1055, 2004.
35. Nagahara A, Miwa H, Minoo T, Hojo M, Kawabe M, Osada T, Kurosawa A, Asaoka D, Terai T, Ohkusa T, Sato N. Increased esophageal sensitivity to acid and saline in patients with non-erosive gastro-esophageal reflux disease. J Clin Gastroenterol 40:891-895,2006.
43. Nagahara A, Miwa H, Hojo M, Yoshizawa T, Kawabe M, Osada T, Kurosawa A, Ohkusa T, Watanabe S. Efficacy of Lansap combination therapy for eradication of H. pylori. Helicobacter 12:643-4, 2007.
64. Nagahara A , Asaoka D, Hojo M , Oguro M , Shimada Y , Ishikawa D, Osada T, Kawabe M, Yoshizawa T, Otaka M, Watanabe S. Observational comparative trial of the efficacy of PPI versus H2RA for uninvestigated dyspepsia. J Gastroenterol Hepatol 25 Suppl 1: S122-S128,2010.IF:3.452/CI:10
65. Kato J, Nagahara A, Iijima K, Kodani T, Higashihara Y, Yoshimura M, Serizawa N, Osada T, Yoshizawa T, Otaka M, Watanabe S. Phase I study of paclitaxel, cisplatin and 5-fluorouracil combination chemotherapy for unresectable / recurrent gastric cancer. Adv Med Sci. 55:137-42.2010.IF:1.364/CI:3
66. Beppu K, Nagahara A, Terai T, Matsumoto K, Shibuya T, Sakamoto N, Osada T,Kawabe M, Otaka M, Ogihara T, Watanabe S. Clinicopathological characteristics of colorectal cancer less than 10 mm in diameter and invading submucosa and below. JGastroenterol Hepatol 25 Suppl 1:S57-61.2010.IF:3.452/CI:4
67. Fukuo Y, Shibuya T, Fukumura Y, Mizui T, Sai JK, Nagahara A, Tsukada A,Matsumoto T, Suyama M, Watanabe S. Reactive lymphoid hyperplasia of the liver associated with primary biliary cirrhosis. Med Sci Monit. 16:CS81-6.2010.IF:1.585/CI:3
68. Shibuya T, Osada T, Mitomi H, Takeda T, Nomura O, Nakayama H, Hidaka Y, Mori H, Beppu K, Sakamoto N, Nagahara A, Otaka M, Ogihara T, Yao T, Watanabe S. Jejunal capillary hemangioma treated by using double-balloon endoscopy (with video). Gastrointest Endosc. 72:660-1.2010.IF:6.501/CI:5
69. Mori H, Shibuya T, Osada T, Kodani T, Higashihara Y, Serizawa N, Kato J, Nagahara A, Ogihara T, Watanabe S. Response to chemotherapy in a case of gastric adenocarcinoma producing granulocyte colony-stimulating factor. Med Sci Monit. 16:CS119-23.2010.IF:1.585/CI:0
70. Matsumoto K, Nagahara A, Terai T, Ueyama H, Ritsuno H, Mori H, Nakae K, Beppu K, Shibuya T, Sakamoto N, Osada T, Ogihara T, Yao T, Watanabe S. Evaluation of new subclassification of type V(I) pit pattern for determining the depth and type of invasion of colorectal neoplasm. J Gastroenterol. 46:31-8.2011.IF: 4.658/CI:8
71. Nakajima K, Nagahara A, Kurosawa A, Seyama K, Asaoka D, Osada T, Hojo M, Watanabe S. Quit smoking improves gastroesophageal reflux symptoms and quality of life. Health 3:677-83.2011. IF:-/CI:0
72. Miwa H, Inoue K, Ashida K, Kogawa T, Nagahara A, Yoshida S, Tano N, Yamazaki Y, Wada T, Asaoka D, Fujita T, Tanaka J, Shimatani T, Manabe N, Oshima T, Haruma K, Azuma T, Yokoyama T; Japan TREND study group. Randomised clinical trial:efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind , placebo-controlled study. Aliment Pharmacol Ther. 33:323-32.2011.IF:7.286/CI:31
73. Matsumoto K, Nagahara A, Sakamoto N, Suyama M, Konuma H, Morimoto T, Sagawa E, Ueyama H, Takahashi T, Beppu K, Shibuya T, Osada T, Yoshizawa T, Ogihara T, Watanabe S. A new traction device for facilitating endoscopic submucosal dissection (ESD) for early gastric cancer: the "medical ring". Endoscopy. 43 Suppl 2 UCTN:E67-8.2011.IF:5.444/CI:18
74. Beppu K, Osada T, Inoue K, Matsumoto K, Shibuya T, Sakamoto N, Kawabe M, Nagahara A, Ogihara T, Watanabe S. Intestinal involvement in Wegener's granulomatosis diagnosed and followed up by double balloon enteroscopy. Intern Med. 50:219-22.2011.IF:0.815/CI:5
75. Itatsu T, Nagahara A, Hojo M, Miyazaki A, Murai T, Nakajima M, Watanabe S. Use of selective serotonin reuptake inhibitors and upper gastrointestinal disease. Intern Med. 50(7):713-7.2011.IF:0.815/CI:8
76. Oguro M, Koike M, Ueno T, Asaoka D, Mori H, Nagahara A, Uchiyama Y, Watanabe S. Dissociation and dispersion of claudin-3 from the tight junction could be one of the most sensitive indicators of reflux esophagitis in a rat model of the disease. J Gastroenterol. 46:629-38.2011.IF:4.658/CI:23
77. Asaoka D, Nagahara A, Oguro M, Mori H, Nakae K, Izumi Y, Osada T, Hojo M, Otaka M, Watanabe S. Establishment of a reflux esophago-laryngitis model in rats. Dig Dis Sci. 56:1299-308.2011.IF:2.875/CI:4
78. Shibuya T, Ohkusa T, Yokoyama T, Matsumoto K, Beppu K, Sakamoto N, Osada T, Nagahara A, Otaka M, Ogihara T, Watanabe S. Colonic mucosal lesions associated with low-dose aspirin: a case control study. Scand J Gastroenterol. 46:810-7.2011.IF:2.526/CI:3
79. Hojo M, Ohkusa T, Tomeoku H, Koido S, Asaoka D, Nagahara A, Watanabe S. Corticotropin-releasing factor secretion from dendritic cells stimulated by commensal bacteria. World J Gastroenterol. 17:4017-22.2011.IF:3.365/CI:5
80. Kodani T, Osada T, Terai T, Ohkusa T, Shibuya T, Sakamoto N, Beppu K, Kato J, Nagahara A, Watanabe H, Watanabe S. Successful endoscopic mucosal resection of a solitary extramedullary plasmacytoma in the sigmoid colon. Endoscopy. 43 Suppl 2 UCTN:E298-9.2011.IF:5.444/CI:3
81. Beppu K, Osada T, Nagahara A, Matsumoto K, Shibuya T, Sakamoto N, Otaka M, Terai T, Ogihara T, Watanabe S. Relationship between endoscopic findings and clinical severity in ischemic colitis. Intern Med. 50:2263-7.2011.IF:0.815/CI:8
82. Mori H, Sakamoto N, Osada T, Ritsuno H, Hidaka Y, Nakae K, Matsumoto K, Beppu K, Shibuya T, Yoshizawa T, Nagahara A, Otaka M, Ogihara T, Arai F, Watanabe S. The 'Loop Clip' is useful for closing large mucosal defects after colorectal endoscopic submucosal dissection: a preliminary clinical study. Dig Endosc. 23:330-1.2011.IF:3.238/CI:3
83. Ritsuno H, Sakamoto N, Mitomi H, Namihisa A, Mori H, Nakae K, Matsumoto K, Beppu K, Shibuya T, Osada T, Nagahara A, Otaka M, Terai T, Ogihara T, Yao T, Watanabe S. Advanced colorectal cancer with double-hump camel-like appearance. Dig Endosc. 23:329.2011.IF:3.238/CI:0
84. Taniguchi G, Nagahara A, Matsumoto K, Ritsuno H, Sasaki H, Igusa Y, Mori H, Beppu K, Shibuya T, Sakamoto N, Osada T, Kawabe M, Terai T, Ogihara T, Watanabe S. Asymptomatic anisakiasis of the colon incidentally found by colonoscopy. Clinical Journal of Gastroenterology 4:371-373. 2011. IF:-/CI:0
85. Takeda T, Shibuya T, Osada T, Izumi H, Mitomi H, Nomura O, Suzuki S, Mori H,Matsumoto K, Kon K, Abe W, Beppu K, Sakamoto N, Nagahara A, Otaka M, Ogihara T,Yao T, Watanabe S. Metastatic renal cell carcinoma diagnosed by capsule endoscopy and double balloon endoscopy. Med Sci Monit. 17:CS15-7. 2011. IF:1.585/CI:6
86. Hojo M, Takahashi T, Nagahara A, Sasaki H, Oguro M, Asaoka D, Watanabe S. Analysis of brain 5activity during visceral stimulation. J Gastroenterol Hepatol. 27 Suppl 3:49-52.2012.IF:3.452/CI:5
87. Nagahara A, Hojo M, Asaoka D, Sasaki H, Oguro M, Mori H, Matsumoto K, Osada T, Yoshizawa T, Watanabe S. Clinical feature of asymptomatic reflux esophagitis in patients who underwent upper gastrointestinal endoscopy. J Gastroenterol Hepatol. 27 Suppl 3:53-7. 2012.IF:3.452/CI:6
88. Sakurai K, Nagahara A, Inoue K, Akiyama J, Mabe K, Suzuki J, Habu Y, Araki A, Suzuki T, Satoh K, Nagami H, Harada R, Tano N, Kusaka M, Fujioka Y, Fujimura T, Shigeto N, Oumi T, Miwa J, Miwa H, Fujimoto K, Kinoshita Y, Haruma K. Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS). BMC Gastroenterol. 12:42.2012.IF:2.212/CI:13
89. Kodani T, Osada T, Matsumoto K, Kato J, Higashihara Y, Morimoto T, Ogata C, Taniguchi G, Mizui T, Matsumura Y, Yoshizawa T, Nagahara A, Mitomi H, Yao T, Watanabe S. Endoscopic mucosal resection using a cap-fitted panendoscope as a diagnostic procedure in a case of scirrhous gastric carcinoma. Dig Endosc. 24:190. 2012.IF:3.238/CI:1
90. Shibuya T, Mori H, Takeda T, Konishi M, Fukuo Y, Matsumoto K, Beppu K, Sakamoto N, Osada T, Nagahara A, Otaka M, Ogihara T, Watanabe S. The relationship between physical activity level and completion rate of small bowel examination in patients undergoing capsule endoscopy. Intern Med. 2012;51:997-1001. 2012.IF:0.815/CI:8
91. Lee SY, Tomoyoshi S, Haga K, Sasaki H, Ogata C, Nomura O, Fukuo Y, Abe W, Osada T, Nagahara A, Ogihara T, Kamiyama H, Sakamoto K, Watanabe S. Multiple carcinoid tumors of the small intestine preoperatively diagnosed by double-balloon endoscopy. Med Sci Monit. 18:CS109-112. 2012.IF:1.585/CI:4
92. Matsumoto K, Nagahara A, Ueyama H, Konuma H, Morimoto T, Sasaki H, Hayashi T, Shibuya T, Sakamoto N, Osada T, Ogihara T, Yao T, Watanabe S. Development and clinical usability of a new traction device "medical ring" for endoscopic submucosal dissection of early gastric cancer. Surg Endosc.27:3444-51, 2013.IF:3.747/CI:2
93. Asaoka D, Nagahara A, Matsuhisa T, Takahashi S, Tokunaga K, Kawai T, Kawakami K, Suzuki H, Suzuki M, Nishizawa T, Kurihara N, Ito M, Sasaki H, Omata F, Mizuno S, Torii A, Ohkusa T, Mine T, Sakaki N. Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area. Helicobacter.18:468-72, 2013.IF:3.429/CI:12
94. Osada T, Sakamoto N, Ritsuno H, Murakami T, Ueyama H, Shibuya T, Matsumoto K,Nagahara A, Ogihara T, Watanabe S. Process of wound healing of large mucosal defect areas that were sutured by using a loop clip-assisted closure technique after endoscopic submucosal dissection of a colorectal tumor. Gastrointest Endosc. 78:793-8, 2013.IF:6.501/CI:4
95. Ueyama H, Matsumoto K, Nagahara A, Gushima R, Hayashi T, Yao T, Watanabe S. A white opaque substance-positive gastric hyperplastic polyp with dysplasia. World J Gastroenterol. 19:4262-6, 2013.IF:3.365/CI:2
96. Iwakiri R, Tominaga K, Furuta K, Inamori M, Furuta T, Masuyama H, Kanke K, Nagahara A, Haruma K, Kinoshita Y, Higuchi K, Takahashi S, Kusano M, Iwakiri K, Kato M, Hongo M, Hiraishi H, Watanabe S, Miwa H, Naito Y, Fujimoto K, Arakawa T. Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan. Aliment Pharmacol Ther. 38:729-40, 2013.IF:7.286/CI:19
97. Takeda T, Murakami T, Sakamoto N, Goto SP, Ritsuno H, Ueyama H, Mori H, Matsumoto K, Shibuya T, Osada T, Nagahara A, Ogihara T, Watanabe S. Traction device to remove an adenoma in the appendiceal orifice by endoscopic submucosal dissection. Endoscopy. 45 Suppl 2:E239-40, 2013.IF:5.444/CI:3
98. Sasaki H, Nagahara A, Hojo M, Asaoka D, Matsumoto K, Osada T, Watanabe S.Ten-Year Trend of the Cumulative Helicobacter pylori Eradication Rate for the 'Japanese Eradication Strategy'. Digestion. 88:272-278, 2013.IF:2.088/CI:5
99. Hirai M, Matsumoto K, Ueyama H, Fukushima H, Murakami T, Sasaki H, Nagahara A, Yao T, Watanabe S. A case of neuroendocrine tumor G1 with unique histopathological growth progress. World J Gastrointest Endosc. 5:605-9, 2013.IF:-/CI:0
100. Koido S, Ohkusa T, Saito H, Yokoyama T, Shibuya T, Sakamoto N, Uchiyama K, Arakawa H, Osada T, Nagahara A, Watanabe S, Tajiri H. Seasonal variations in the onset of ulcerative colitis in Japan. World J Gastroenterol.19:9063-8, 2013.IF:3.365/CI:2
101. Ueyama H, Matsumoto K, Nagahara A, Hayashi T, Yao T, Watanabe S. Gastric adenocarcinoma of the fundic gland type (chief cell predominant type). Endoscopy. 46:153-7, 2014.IF:5.444/CI:15
102. Nagahara A, Suzuki T, Nagata N, Sugai N, Takeuchi Y, Sakurai K, Miyamoto M, Inoue K, Akiyama J, Mabe K, Konuma I, Kamada T, Haruma K. A multicentre randomised trial to compare the efficacy of omeprazole versus rabeprazole in early symptom relief in patients with reflux esophagitis. J Gastroenterol. 49:1536-47, 2014.IF: 4.658/CI:3
103. Higashihara Y, Kato J, Nagahara A, Izumi K, Konishi M, Kodani T, Serizawa N, Osada T, Watanabe S. Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer. Int J Oncol. 44:662-8, 2014.IF:3.079/CI:5
104. Konishi M, Shibuya T, Mori H, Kurashita E, Takeda T, Nomura O, Fukuo Y, Matsumoto K, Sakamoto N, Osada T, Nagahara A, Ogihara T, Watanabe S. Usefulness of flexible spectral imaging color enhancement for the detection and diagnosis of small intestinal lesions found by capsule endoscopy. Scand J Gastroenterol. 49:501-5, 2014.IF:2.526/CI:7
105. Nagahara A, Hojo M, Asaoka D, Sasaki H, Watanabe S. A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan. Scand J Gastroenterol. 49:409-17, 2014.IF:2.526/CI:8
106. Tominaga K, Kato M, Takeda H, Shimoyama Y, Umegaki E, Iwakiri R, Furuta K, Sakurai K, Odaka T, Kusunoki H, Nagahara A, Iwakiri K, Furuta T, Murakami K, Miwa H, Kinoshita Y, Haruma K, Takahashi S, Watanabe S, Higuchi K, Kusano M, Fujimoto K, Arakawa T; G-PRIDE Study Group. A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study. J Gastroenterol. 49:1392-405, 2014.IF: 4.658/CI:13
107. Izumi K, Osada T, Sakamoto N, Kodani T, Higashihara Y, Ritsuno H, Shibuya T, Nagahara A, Ogihara T, Kikuchi K, Watanabe S. Frequent occurrence of fever in patients who have undergone endoscopic submucosal dissection for colorectal tumor, but bacteremia is not a significant cause. Surg Endosc. 28:2899-904, 2014.IF:3.747/CI:3
108. Ritsuno H, Sakamoto N, Osada T, Goto SP, Murakami T, Ueyama H, Mori H, Matsumoto K, Beppu K, Shibuya T, Nagahara A, Ogihara T, Watanabe S. Prospective clinical trial of traction device-assisted endoscopic submucosal dissection of large superficial colorectal tumors using the S-O clip. Surg Endosc. 28:3143-9, 2014.IF:3.747/CI:11
109. Suyama M, Koike M, Asaoka D, Mori H, Oguro M, Ueno T, Nagahara A, Watanabe S, Uchiyama Y. Increased Immunoreactivity of Cathepsins in the Rat Esophagus under Chronic Acid Reflux Esophagitis. J Histochem Cytochem. 62:645-60, 2014.IF:2.511/CI:1
110. Koido S, Ohkusa T, Nakae K, Yokoyama T, Shibuya T, Sakamoto N, Uchiyama K, Arakawa H, Osada T, Nagahara A, Watanabe S, Tajiri H. Factors associated with incomplete colonoscopy at a Japanese academic hospital. World J Gastroenterol.20:6961-7, 2014.IF:3.365/CI:7
111. Sakata Y, Tominaga K, Kato M, Takeda H, Shimoyama Y, Takeuchi T, Iwakiri R, Furuta K, Sakurai K, Odaka T, Kusunoki H, Nagahara A, Iwakiri K, Furuta T, Murakami K, Miwa H, Kinoshita Y, Haruma K, Takahashi S, Watanabe S, Higuchi K, Fujimoto K, Kusano M, Arakawa T; G-PRIDE study group. Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito. BMC Gastroenterol. 14:116, 2014.IF:2.212/CI:8
112. Asaoka D, Nagahara A, Hojo M, Sasaki H, Shimada Y, Yoshizawa T, Osada T, Watanabe S. The Relationship between H. pylori Infection and Osteoporosis in Japan. Gastroenterol Res Pract. 340765, 2014.IF:1.863/CI:2
113. Goto SP, Sakamoto N, Mitomi H, Murakami T, Ritsuno H, Ueyama H, Matsumoto K, Shibuya T, Osada T, Nagahara A, Ogihara T, Yao T, Watanabe S. Histological Distinction between the Granular and Nongranular Types of Laterally Spreading Tumors of the Colorectum. Gastroenterol Res Pract. 153935, 2014.IF:1.863/CI:0
114. Kumagai E, Shibuya T, Makino M, Murakami T, Takashima S, Ritsuno H, Ueyama H,　Kodani T, Sasaki H, Matsumoto K, Sakamoto N, Osada T, Nagahara A, Ogihara T,　Watanabe S. A Randomized Prospective Study of Bowel Preparation for Colonoscopy　with Low-Dose Sodium Phosphate Tablets versus Polyethylene Glycol Electrolyte　Solution. Gastroenterol Res Pract. 879749, 2014.IF:1.863/CI:0
115. Morinaga M, Osada T, Kon K, Kato J, Konishi M, Shibuya T, Sakamoto N, Nagahara A, Yao T, Fujime M, Watanabe S. Metastatic seminoma in the duodenum: diagnosis with endoscopy followed by successful treatment. Intern Med. 53:2777-81, 2014.IF:0.815/CI:0
116. Hojo M, Nagahara A, Asaoka D, Ueyama H, Shimada Y, Matsumoto K, Watanabe S. Symptoms of Gastro-Esophageal Reflux Disease: A Comparative Study between Elderly and Younger Patients in Japan. Health 6:1700-5, 2014.IF:-/CI:0
117. Kawai T, Takahashi S, Suzuki H, Sasaki H, Nagahara A, Asaoka D, Matsuhisa T, Masaoaka T, Nishizawa T, Suzuki M, Ito M, Kurihara N, Omata F, Mizuno S, Torii A, Kawakami K, Ohkusa T, Tokunaga K, Mine T, Sakaki N. Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group). J Gastroenterol Hepatol. 29 Suppl 4:29-32, 2014.IF:3.452/CI:11
118. Beppu K, Osada T, Sakamoto N, Shibuya T, Matsumoto K, Nagahara A, Terai T, Ogihara T, Watanabe S. Optimal timing for resuming antithrombotic agents and risk factors for delayed bleeding after endoscopic resection of colorectal tumors. Gastroenterol Res Pract. 825179, 2014.IF:1.863/CI:2
119. Shimada Y, Nagahara A, Hojo M, Asaoka D, Sasaki H, Ueyama H, Matsumoto K, Watanabe S. Upper gastrointestinal mucosal injury and symptoms in elderly low-dose aspirin users. Gastroenterol Res Pract. 252963, 2015.IF:1.863/CI:0
120. Nagahara A, Miwa H, Asaoka D, Shimada Y, Sasaki H, Matsumoto K, Osada T, Hojo M, Watanabe S. Pretreatment prediction of symptom response to proton pump inhibitor therapy. J Gastroenterol Hepatol. 30 Suppl 1:25-30, 2015.IF:3.452/CI:0
121. Asaoka D, Nagahara A, Shimada Y, Matsumoto K, Ueyama H, Matsumoto K, Nakagawa Y, Takeda T, Tanaka I, Sasaki H, Osada T, Hojo M, Watanabe S. Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori? Ther Clin Risk Manag. 11:381-91. 2015.IF:2.200/CI:5
122. Murakami T, Yao T, Mitomi H, Morimoto T, Ueyama H, Matsumoto K, Saito T, Osada T, Nagahara A, Watanabe S. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases. Gastric Cancer. 19:498-507, 2016.IF:5.454/CI:3
123. Obayashi N, Ohtsuka Y, Hosoi K, Ikuse T, Jimbo K, Aoyagi Y, Fujii T, Kudo T, Asaoka D, Hojo M, Nagahara A, Watanabe S, Shimizu T. Comparison of Gene Expression Between Pediatric and Adult Gastric Mucosa with Helicobacter pylori Infection. Helicobacter. 21:114-23, 2016.IF:3.429/CI:3
124. Ito T, Nagahara A, Osada T, Kato J, Ueyama H, Saito H, Taniki N, Kanazawa R, Shimizu R, Sai J, Shiina S, Watanabe S. Efficacy of recombinant human soluble thrombomodulin in patients with sepsis and disseminated intravascular coagulation in the gastroenterology field. Biomed Rep. 3:457-460, 2015.IF:-/CI:1
125. Matsumoto K, Nagahara A, Matsumoto K, Akazawa Y, Komori H, Nakagawa Y, Takeda T, Ueyama H, Shimada Y, Asaoka D, Hojo M, Watanabe S. Optimization of Deep Sedation with Spontaneous Respiration for Therapeutic Endoscopy Combining Propofol and Bispectral Index Monitoring. Gastroenterol Res Pract. 282149, 2015.IF:1.863/CI:0
126. Nagahara A, Asaoka D, Hojo M, Sasaki H, Shimada Y, Matsumoto K, Ueyama H, Shibuya T, Sakamoto N, Osada T, Watanabe S. Difference in efficacy of proton pump inhibitor between new-onset and recurrent gastroesophageal reflux disease: Result from a study of on-demand versus continuous maintenance therapy in Japan. Hippokratia. 19:53-6, 2015.IF:0.467/CI:0
127. Sato S, Genda T, Ichida T, Murata A, Tsuzura H, Narita Y, Kanemitsu Y, Ishikawa S, Kikuchi T, Mori M, Hirano K, Iijima K, Wada R, Nagahara A, Watanabe S. Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma. J Gastroenterol Hepatol. 31:1315-22, 2016.IF:3.452/CI:3
128. Asaoka D, Nagahara A, Hojo M, Matsumoto K, Ueyama H, Matsumoto K, Izumi K, Takeda T, Komori H, Akazawa Y, Shimada Y, Osada T, Watanabe S. Efficacy of alfacalcidol and alendronate on lumbar bone mineral density in osteoporotic patients using proton pump inhibitors. Biomed Rep. 5:165-170, 2016.IF:-/CI:0
129. Ueyama H, Yao T, Matsumoto K, Nakagawa Y, Takeda T, Matsumoto K, Nagahara A, Watanabe S. Flat-type primary malignant melanoma of the esophagus. Endosc Int Open. 4:E687-9, 2016. IF:-/CI:0
130. Murata A, Genda T, Ichida T, Amano N, Sato S, Tsuzura H, Sato S, Narita Y, Kanemitsu Y, Shimada Y, Hirano K, Iijima K, Wada R, Nagahara A, Watanabe S. Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication. World J Gastroenterol. 22:7569-78, 2016.IF:3.365/CI:0
131. Matsumoto K, Ueyama H, Matsumoto K, Akazawa Y, Komori H, Takeda T, Murakami T, Asaoka D, Hojo M, Tomita N, Nagahara A, Kajiyama Y, Yao T, Watanabe S. Clinicopathological features of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation. World J Gastroenterol. 22:8203-10, 2016.IF:3.365/CI:1
132. Asaoka D, Nagahara A, Hojo M, Matsumoto K, Ueyama H, Matsumoto K, Izumi K, Takeda T, Komori H, Akazawa Y, Shimada Y, Osada T, Watanabe S. Association of medications for lifestyle-related diseases with reflux esophagitis. Ther Clin Risk Manag. 12:1507-1515, 2016. IF:2.200/CI:0
133. Sato S, Genda T, Ichida T, Amano N, Sato S, Murata A, Tsuzura H, Narita Y, Kanemitsu Y, Hirano K, Shimada Y, Iijima K, Wada R, Nagahara A, Watanabe S. Prediction of Hepatocellular Carcinoma Development after Hepatitis C Virus Eradication Using Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein. Int J Mol Sci. 17. pii: E2143, 2016.IF:3.226/CI:0
134. Konuma H, Matsumoto K, Ueyama H, Komori H, Akazawa Y, Ueyama M, Nakagawa Y, Morimoto T, Takeda T, Matsumoto K, Asaoka D, Hojo M, Nagahara A, Yao T, Miyazaki A, Watanabe S. Procedure Time for Gastric Endoscopic Submucosal Dissection according to Location, considering Both Mucosal Circumferential Incision and Submucosal Dissection. Gastroenterol Res Pract. 9183793, 2016.IF1.863/CI:0
135. Mori M, Genda T, Ichida T, Murata A, Kamei M, Tsuzura H, Sato S, Narita Y, Kanemitsu Y, Ishikawa S, Kikuchi T, Shimada Y, Hirano K, Iijima K, Sugimoto K, Wada R, Nagahara A, Watanabe S. Aldo-keto reductase family 1 member B10 is associated with hepatitis B virus-related hepatocellular carcinoma risk. Hepatol Res. 47:E85-E93, 2017.IF:2.602/CI:0
136. Shibuya T, Nomura O, Kodani T, Murakami T, Fukushima H, Tajima Y, Matsumoto K, Ritsuno H, Ueyama H, Inami Y, Ishikawa D, Matsumoto K, Sakamoto N, Osada T, Nagahara A, Ogihara T, Watanabe S. Continuation of antithrombotic therapy may be associated with a high incidence of colonic post-polypectomy bleeding. Dig Endosc. 29:314-321, 2017.IF:3.238/CI:0
137. Okada E, Ukawa S, Nakamura K, Hirata M, Nagai A, Matsuda K, Ninomiya T, Kiyohara Y, Muto K, Kamatani Y, Yamagata Z, Kubo M, Nakamura Y; BioBank Japan Cooperative Hospital Group, Tamakoshi A. Demographic and lifestyle factors and survival among patients with esophageal and gastric cancer: The Biobank Japan Project (Members of medical institutions cooperating in the BioBank Japan Project who coauthored this paper include Rai Shimoyama, Shinichiro Makimoto, Hiromasa Harada and Tomoaki Fujikawa (Tokushukai Hospitals); Shiro Minami, Eiji Uchida and Masao Miyashita (Nippon Medical School); Yoshiaki Kajiyama, Natsumi Tomita and Akihito Nagahara (Juntendo University); Satoshi Asai, Mitsuhiko Moriyama and Yasuo Takahashi (Nihon University); Tomoaki Fujioka and Wataru Obara (Iwate Medical University); Seijiro Mori and Hideki Ito (Tokyo Metropolitan Institute of Gerontology); Satoshi Nagayama and Yoshio Miki (The Cancer Institute Hospital of JFCR); Akihide Masumoto and Akira Yamada (Aso Iizuka Hospital); Yasuko Nishizawa and Ken Kodama (Osaka Medical Center for Cancer and Cardiovascular Diseases); Hiromitsu Ban and Satoshi Murata (Shiga University of Medical Science); Yukihiro Koretsune and Motohiro Hirao (National Hospital Organization, Osaka National Hospital); and Hideo Ogata (Fukujuji Hospital).). J Epidemiol. 27(3S):S29-S35, 2017.IF:2.447/CI:1
138. Asaoka D, Nagahara A, Hojo M, Matsumoto K, Ueyama H, Matsumoto K, Izumi K, Takeda T, Komori H, Akazawa Y, Shimada Y, Osada T, Watanabe S. Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis, non-erosive reflux disease, and functional dyspepsia. Biomed Rep. 6:175-180, 2017.IF:-/CI:0
139. Hojo M, Nagahara A, Asaoka D, Takeda T, Izumi K, Matsumoto K, Ueyama H, Shimada Y, Matsumoto K, Nojiri S, Watanabe S. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia. Digestion. 96:5-12, 2017. IF:2.088/CI:0
140. Takeda T, Asaoka D, Tajima Y, Matsumoto K, Takeda N, Hiromoto T, Okubo S, Saito H, Aoyama T, Shibuya T, Sakamoto N, Hojo M, Osada T, Nagahara A, Yao T, Watanabe S. Hemorrhagic polyps formed like fundic gland polyps during long-term proton pump inhibitor administration. Clin J Gastroenterol. 2017 Oct;10(5):478-484. Epub 2017 Jun 28. PubMed PMID:　28660530; PubMed Central PMCID: PMC5606985.
141. Hojo M, Nagahara A, Asaoka D, Shimada Y, Sasaki H, Matsumoto K, Tkaedda T, Ueyama H, Matsumoto K, Watanabe S. A Systematic Review of the Effectiveness of Antianxiety and Antidepressive Agents for Functional Dyspepsia. Intern Med. 2017.Dec 1;56(23):3127-3133. doi: 10.2169/internalmedicine.9099-17. Epub 2017 Oct 11. PubMed PMID: 29021437; PubMed Central PMCID: PMC5742382.IF:0.815/CI:0
142. Takeda T, Nagahara A, Ishizuka K, Okubo S, Haga K, Suzuki M, Nakajima A,　Komori H, Akazawa Y, Izumi K, Matsumoto K, Ueyama H, Shimada Y, Matsumoto K,　Asaoka D, Shibuya T, Sakamoto N, Osada T, Hojo M, Nojiri S, Watanabe S. Improved Visibility of Barrett's Esophagus with Linked Color Imaging: Inter- and Intra-Rater Reliability and Quantitative Analysis. Digestion. 2018;97(2):183-194. doi: 10.1159/000485459. Epub 2018 Jan 10. PubMed PMID: 29320766.
143. Kamei M, Shibuya T, Takahashi M, Makino M, Haga K, Nomura O, Murakami T, Ritsuno H, Ueyama H, Kodani T, Ishikawa D, Matsumoto K, Sakamoto N, Osada T, Ogihara T, Watanabe S, Nagahara A. Efficacy and Acceptability of 1 Liter of Polyethylene Glycol with Ascorbic Acid vs. 2 Liters of Polyethylene Glycol Plus Mosapride and Sennoside for Colonoscopy Preparation. Med Sci Monit. 2018 Jan 26;24:523-530. PubMed PMID: 29373569; PubMed Central PMCID: PMC5795919.
144. Tsuruoka N, Iwakiri R, Sakata Y, Fujimoto K, Kamiya T, Joh T, Tokunaga K, Takahashi S, Kinoshita Y, Uchiyama K, Naito Y, Nagahara A, Watanabe T, Chan FKL, Hahm KB, Kachintorn U, Fock KM, Syam AF, Rani AA, Sollano JD, Zhu Q. Questionnaire-Based Survey on Gastrointestinal Bleeding and Management of Antithrombotic Agents during Endoscopy Among Asian Countries. Digestion. 2018;97(1):97-106. doi: 10.1159/000484228. Epub 2018 Feb 2. PubMed PMID: 29402809.
145. Ikuse T, Ohtsuka Y, Obayashi N, Jimbo K, Aoyagi Y, Kudo T, Asaoka D, Hojo M, Nagahara A, Watanabe S, Blanchard TG, Czinn SJ, Shimizu T. Host response genes associated with nodular gastritis in H. pylori infection. Pediatr Int. 2018 Feb 7. doi: 10.1111/ped.13527. [Epub ahead of print] PubMed PMID: 29415337.
146. Tominaga K, Sakata Y, Kusunoki H, Odaka T, Sakurai K, Kawamura O, Nagahara A, Takeuchi T, Fujikawa Y, Oshima T, Kato M, Furuta T, Murakami K, Chiba T, Miwa H, Kinoshita Y, Higuchi K, Kusano M, Iwakiri R, Fujimoto K, Tack JF, Arakawa T. Rikkunshito simultaneously improves dyspepsia correlated with anxiety in patients with functional dyspepsia: A randomized clinical trial (the DREAM study). Neurogastroenterol Motil. 2018 Mar 2. doi: 10.1111/nmo.13319. [Epub ahead of print] PubMed PMID: 29498457.
147. Hiromoto T, Murakami T, Akazawa Y, Sasahara N, Saito T, Sakamoto N, Mitomi H, Nagahara A, Yao T. Immunohistochemical and genetic characteristics of a colorectal mucin-rich variant of traditional serrated adenoma. Histopathology. 2018 May 5. doi: 10.1111/his.13643. [Epub ahead of print] PubMed PMID: 29729192.
148. Tomishima K, Sato S, Amano N, Murata A, Tsuzura H, Sato S, Kanemitsu Y, Shimada Y, Iijima K, Genda T, Wada R, Nagahara A. A case of ischemic gastroduodenal disease in a patient who was receiving hemodialysis treatment that was managed by conservative treatment. Clin J Gastroenterol. 2018 May 8. doi:10.1007/s12328-018-0865-1. [Epub ahead of print] PubMed PMID: 29737481.
149. Akazawa Y, Saito T, Hayashi T, Yanai Y, Tsuyama S, Akaike K, Suehara Y, Takahashi F, Takamochi K, Ueyama H, Murakami T, Watanabe S, Nagahara A, Yao T. Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: emphasis on the relationship with hepatoid adenocarcinoma. Hum Pathol. 2018 Aug;78:79-88. doi: 10.1016/j.humpath.2018.04.022. Epub 2018 May 8. PubMed PMID: 29751042.
150. Hojo M, Asahara T, Nagahara A, Takeda T, Matsumoto K, Ueyama H, Matsumoto K, Asaoka D, Takahashi T, Nomoto K, Yamashiro Y, Watanabe S. Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors. Dig Dis Sci. 2018 May 24. doi: 10.1007/s10620-018-5122-4. [Epub ahead of print] PubMed PMID: 29796911.
151. Akazawa Y, Ueyama H, Yao T, Komori H, Takeda T, Matsumoto K, Matsumoto K, Asaoka D, Hojo M, Watanabe S, Nagahara A. Usefulness of Demarcation of Differentiated-Type Early Gastric Cancers after Helicobacter pylori Eradication by Magnifying Endoscopy with Narrow-Band Imaging. Digestion. 2018 Jun 5;98(3):175-184. doi: 10.1159/000489167. [Epub ahead of print] PubMed PMID:29870997.
152. Takeda T, Matsumoto K, Nagahara A, Komori H, Akazawa Y, Nakagawa Y, Izumi K, Matsumoto K, Ueyama H, Shimada Y, Asaoka D, Hojo M, Yao T, Watanabe S. Effect of Esophageal Endoscopic Submucosal Dissection on Motility and Symptoms: A Prospective Study. Gastroenterol Res Pract. 2018 Jun 3;2018:3735473. doi: 10.1155/2018/3735473. eCollection 2018. PubMed PMID: 29967638; PubMed Central PMCID: PMC6008697.
153.Murakami T, Sakamoto N, Nagahara A. Endoscopic diagnosis of sessile serrated adenoma/polyp with and without dysplasia/carcinoma. World J Gastroenterol. 2018Aug 7;24(29):3250-3259. doi: 10.3748/wjg.v24.i29.3250. Review. PubMed PMID: 30090005; PubMed Central PMCID: PMC6079289.
154.Shibuya T, Haga K, Kamei M, Okahara K, Ito S, Takahashi M, Nomura O, Murakami T, Makino M, Kodani T, Ishikawa D, Sakamoto N, Osada T, Ogihara T, Watanabe S, Nagahara A. Successful remission of ulcerative colitis flare-up during pregnancy with adsorptive granulomonocytapheresis plus tacrolimus. Intest Res. 2018 Jul;16(3):484-488. doi: 10.5217/ir.2018.16.3.484. Epub 2018 Jul 27. PubMed PMID: 30090048; PubMed Central PMCID: PMC6077305.
155.Ishikawa D, Sasaki T, Takahashi M, Kuwahara-Arai K, Haga K, Ito S, Okahara K, Nakajima A, Shibuya T, Osada T, Hiramatsu K, Watanabe S, Nagahara A. The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics. Inflamm Bowel Dis. 2018 Nov 29;24(12):2590-2598. doi: 10.1093/ibd/izy266. PubMed PMID: 30124831.
156.Murakami T, Akazawa Y, Yatagai N, Hiromoto T, Sasahara N, Saito T, Sakamoto N, Nagahara A, Yao T. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study. Diagn Pathol. 2018 Nov 20;13(1):88. doi: 10.1186/s13000-018-0771-3. PubMed PMID: 30458818; PubMed Central PMCID: PMC6247685
157.Takahashi M, Ishikawa D, Sasaki T, Lu YJ, Kuwahara-Arai K, Kamei M, Shibuya T, Osada T, Hiramatsu K, Nagahara A. Faecal freezing preservation period influences colonization ability for faecal microbiota transplantation. J Appl Microbiol. 2018 Nov 29. doi: 10.1111/jam.14167. [Epub ahead of print] PubMed PMID: 30489686.
158.Yamaguchi S, Sasaki K, Kato H, Fukudo S, Iwakiri R, Kamiya T, Motoya S, Murakami K, Nagahara A, Suzuki H, Watanabe T, Takahashi S, Chan FKL, Hahm KB, Kachintorn U, Ming FK, Rani AA, Sollano JD, Zhu Q. Questionnaire-Based Survey on Management of Ulcerative Colitis-Associated Cancer in East Asian Countries. Digestion. 2019;99(1):86-94. doi: 10.1159/000494419. Epub 2018 Dec 14. PubMed PMID: 30554204.
159.Yatagai N, Saito T, Akazawa Y, Hayashi T, Yanai Y, Tsuyama S, Ueyama H, Murakami T, Watanabe S, Nagahara A, Yao T. TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation. Virchows Arch. 2018 Dec 15. doi: 10.1007/s00428-018-2508-9. [Epub ahead of print] PubMed PMID: 30554333.
160.Akazawa Y, Hayashi T, Saito T, Niwa K, Kamiyama H, Sasahara N, Sakamoto K, Nagahara A, Yao T. Histological characteristics of eosinophilic myenteric ganglionitis: an under-recognised cause of chronic intestinal pseudo-obstruction. Virchows Arch. 2019 Jan 4. doi: 10.1007/s00428-018-02513-5. [Epub ahead of print] PubMed PMID: 30607555.
161.Komori H, Ueyama H, Nagahara A, Akazawa Y, Takeda T, Matsumoto K, Matsumoto K, Asaoka D, Hojo M, Yao T, Watanabe S. A prospective randomized trial of a potassium competitive acid blocker vs proton pump inhibitors on the effect of ulcer healing after endoscopic submucosal dissection of gastric neoplasia. J Int Med Res. 2019 Apr;47(4):1441-1452. doi: 10.1177/0300060519828514. Epub 2019 Feb 28. PubMed PMID: 30816056; PubMed Central PMCID: PMC6460617.
162.Yatagai N, Saito T, Akazawa Y, Hayashi T, Yanai Y, Tsuyama S, Murakami T, Ueyama H, Watanabe S, Nagahara A, Yao T. Frequent loss of heterozygosity of SMAD4 locus and prognostic impacts of SMAD4 immunohistochemistry in gastric adenocarcinoma with enteroblastic differentiation. Hum Pathol. 2019 Jun;88:18-26. doi: 10.1016/j.humpath.2019.03.005. Epub 2019 Apr 1. PubMed PMID: 30946932.
163.Asaoka D, Takeda T, Sasaki H, Shimada Y, Matsumoto K, Ueyama H, Matsumoto K, Izumi K, Komori H, Akazawa Y, Osada T, Hojo M, Nagahara A. Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users. Biomed Rep. 2019 May;10(5):277-282. doi: 10.3892/br.2019.1206. Epub 2019 Apr 9. PubMed PMID: 31086661; PubMed Central PMCID: PMC6489533.
164.Murakami T, Sakamoto N, Nagahara A. Clinicopathological features, diagnosis, and treatment of sessile serrated adenoma/polyp with dysplasia/carcinoma. J Gastroenterol Hepatol. 2019 Oct;34(10):1685-1695. doi: 10.1111/jgh.14752. Epub 2019 Jun 30. PMID: 31158302.
165.Takeda T, Asaoka D, Nojiri S, Nishiyama M, Ikeda A, Yatagai N, Ishizuka K, Hiromoto T, Okubo S, Suzuki M, Nakajima A, Nakatsu Y, Komori H, Akazawa Y, Nakagawa Y, Izumi K, Matsumoto K, Ueyama H, Sasaki H, Shimada Y, Matsumoto K, Osada T, Hojo M, Kato M, Nagahara A. Linked Color Imaging and the Kyoto Classification of Gastritis: Evaluation of Visibility and Inter-RaterReliability. Digestion. 2019 Jul 12:1-10. doi: 10.1159/000501534. [Epub ahead of print] PubMed PMID: 31302654.
166.Murakami T, Yao T, Yatagai N, Yamashiro Y, Saito T, Sakamoto N, Nagahara A. Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological study of five cases. Histopathology. 2020 Jan;76(2):325-332. doi: 10.1111/his.13973. Epub 2019 Oct 30. PMID: 31429980.
167.Uchida S, Izawa K, Ando T, Yamada H, Uchida K, Negishi N, Kaitani A, Maehara A, Nagamine M, Kamei A, Takamori A, Maeda K, Nakano N, Shimizu T, Ogawa H, Okumura K, Nagahara A, Watanabe S, Kitaura J. CD300f is a potential therapeutic target for the treatment of food allergy. Allergy. 2020 Feb;75(2):471-474. doi: 10.1111/all.14034. Epub 2019 Oct 2. PMID: 31471969..
168.Amano N, Ikeda Y, Hayashida S, Takahashi S, Sato S, Murata A, Tsuzura H, Sato S, Shimada Y, Iijima K, Wada R, Nagahara A, Genda T. Prognostic significance of serum tyrosine concentration in patients with primary biliary cholangitis under ursodeoxycholic acid therapy. Hepatol Res. 2020Feb;50(2):214-223. doi: 10.1111/hepr.13434. Epub 2020 Jan 5. PMID: 31652380.
169.Shibuya T, Nomura O, Nomura K, Okahara K, Haga K, Ishikawa D, Sakamoto N, Ogihara T, Osada T, Nagahara A. Effectiveness of Cytapheresis for Ulcerative Colitis in Special Situations: Delayed Onset of Optimum Efficacy in Elderly Patients. Digestion. 2020;101(1):46-52. doi: 10.1159/000504091. Epub 2019 Nov 13. PMID: 31722366.
170.Hojo M, Nagahara A, Hahm KB, Iwakiri R, Watanabe T, Rani AA, Zhu Q, Chan FKL, Sollano JD, Kamiya T, Yamaguchi S, Motoya S, Fock KM, Fukudo S, Kachintorn U, Suzuki H, Murakami K; The International Gastroenterology Consensus Symposium Study Group. Management of Gastroesophageal Reflux Disease in Asian Countries: Results of a Questionnaire Survey. Digestion. 2020;101(1):66-79. doi: 10.1159/000504749. Epub 2019 Dec 4. PMID: 31801133.
171.Sato S, Sato S, Tsuzura H, Ikeda Y, Hayashida S, Takahashi S, Amano N, Murata A, Shimada Y, Iijima K, Nagahara A, Genda T. Elevated serum procalcitonin levels and their association with the prognosis of patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2019 Dec 16. doi: 10.1097/MEG.0000000000001644. Epub ahead of print. PMID: 31851098.
172.Shibuya T, Nomura K, Okahara K, Haga K, Nomura O, Murakami T, Uchida S, Kodani T, Ishikawa D, Sakamoto N, Ogihara T, Osada T, Nagahara A. Budesonide Foam for Ulcerative Colitis Patients Experiencing Inadequate Response to Biological Therapy. Med Sci Monit. 2019 Dec 22;25:9855-9863. doi: 10.12659/MSM.918562. PMID: 31865359; PMCID: PMC6939661.
173.Matsumoto K, Konuma H, Ueyama H, Komori H, Akazawa Y, Ueyama M, Takeda T, Matsumoto K, Asaoka D, Hojo M, Yao T, Nagahara A. Multibending scope use for reduction of perforation risks in endoscopic submucosal dissection. Minim Invasive Ther Allied Technol. 2020 Feb 28:1-9. doi: 10.1080/13645706.2019.1688352. Epub ahead of print. PMID: 32108547.
174.Okubo H, Ando H, Ishizuka K, Kitagawa R, Okubo S, Saito H, Kokubu S, Miyazaki A, Ikejima K, Shiina S, Nagahara A. Carnitine insufficiency is associated with fatigue during lenvatinib treatment in patients with hepatocellular carcinoma. PLoS One. 2020 Mar 3;15(3):e0229772. doi: 10.1371/journal.pone.0229772. PMID: 32126131; PMCID: PMC7053710.
175.Nakajima A, Habu S, Kasai M, Okumura K, Ishikawa D, Shibuya T, Kobayashi O, Osada T, Ohkusa T, Watanabe S, Nagahara A. Impact of maternal dietary gut microbial metabolites on an offspring's systemic immune response in mouse models. Biosci Microbiota Food Health. 2020;39(2):33-38. doi: 10.12938/bmfh.19-013. Epub 2020 Jan 25. PMID: 32328398; PMCID: PMC7162694.
176.Nakajima A, Sasaki T, Itoh K, Kitahara T, Takema Y, Hiramatsu K, Ishikawa D, Shibuya T, Kobayashi O, Osada T, Watanabe S, Nagahara A. A soluble fiber diet increases Bacteroides fragilis group and IgA production in the gut. Appl Environ Microbiol. 2020 Apr 24:AEM.00405-20. doi: 10.1128/AEM.00405-20. Epub ahead of print. PMID: 32332136.
177. Okahara K, Ishikawa D, Nomura K, Ito S, Haga K, Takahashi M, Shibuya T, Osada T, Nagahara A. Matching between Donors and Ulcerative Colitis Patients Is Important for Long-Term Maintenance after Fecal Microbiota Transplantation. J Clin Med. 2020 May 31;9(6):1650. doi: 10.3390/jcm9061650. PMID: 32486476; PMCID: PMC7355579.
178. Akazawa Y, Ueyama H, Tsuyama S, Ikeda A, Yatagai N, Komori H, Takeda T, Matsumoto K, Matsumoto K, Hashimoto T, Tomita N, Kajiyama Y, Kato M, Yao T, Nagahara A. Endoscopic and Clinicopathological Features of Superficial Non- Ampullary Duodenal Tumor Based on the Mucin Phenotypes. Digestion. 2020 Jun 9:1-8. doi: 10.1159/000508040. Epub ahead of print. PMID: 32516774.
179. Haga K, Shibuya T, Nomura K, Okahara K, Nomura O, Ishikawa D, Sakamoto N, Osada T, Nagahara A. Effectiveness and Nephrotoxicity of Long-Term Tacrolimus Administration in Patients with Ulcerative Colitis. J Clin Med. 2020 Jun 7;9(6):1771. doi: 10.3390/jcm9061771. PMID: 32517388; PMCID: PMC7355962.
180. Asaoka D, Takeda T, Inami Y, Abe D, Shimada Y, Matsumoto K, Ueyama H, Matsumoto K, Komori H, Akazawa Y, Osada T, Hojo M, Nagahara A. The Association between Frailty and Abdominal Symptoms: A Hospital-based Cross-sectional Study. Intern Med. 2020;59(14):1677-1685. doi: 10.2169/internalmedicine.4399-19. Epub 2020 Jul 15. PMID: 32669514.
181. Ueyama H, Kato Y, Akazawa Y, Yatagai N, Komori H, Takeda T, Matsumoto K, Ueda K, Matsumoto K, Hojo M, Yao T, Nagahara A, Tada T. Application of artificial intelligence using a convolutional neural network for diagnosis of early gastric cancer based on magnifying endoscopy with narrow-band imaging. J Gastroenterol Hepatol. 2021 Feb;36(2):482-489. doi: 10.1111/jgh.15190. Epub 2020 Jul 28. PMID: 32681536; PMCID: PMC7984440.
182. Shibuya T, Haga K, Saeki M, Haraikawa M, Tsuchihashi H, Okahara K, Nomura O, Fukushima H, Murakami T, Ishikawa D, Ikeda S, Nagahara A. Pyoderma gangrenosum in an ulcerative colitis patient during treatment with vedolizumab responded favorably to adsorptive granulocyte and monocyte apheresis. J Clin Apher. 2020 Sep;35(5):488-492. doi: 10.1002/jca.21821. Epub 2020 Aug 7. PMID: 32767842.
183. Hayashida S, Sato S, Shimada Y, Tsuzura H, Ikeda Y, Takahashi S, Sato S, Amano N, Murata A, Nagahara A, Genda T. Eosinophilic Gastroenteritis in an Ulcerative Colitis Patient During Treatment with Tumor Necrosis Factor-alpha Antagonist. Intern Med. 2020;59(16):1977-1981. doi: 10.2169/internalmedicine.4554-20. Epub 2020 Aug 15. PMID: 32801271; PMCID: PMC7492116.
184. Abe D, Takeda T, Ueyama H, Yao T, Nagahara A. Microperforation due to segmental absence of intestinal musculature during endoscopic submucosal dissection for early esophageal cancer: a case study. VideoGIE. 2020 Jul 5;5(8):339-341. doi: 10.1016/j.vgie.2020.04.002. PMID: 32817923; PMCID: PMC7426616.
185. Murakami T, Sakamoto N, Fukushima H, Shibuya T, Yao T, Nagahara A. Usefulness of the Japan narrow-band imaging expert team classification system for the diagnosis of sessile serrated lesion with dysplasia/carcinoma. Surg Endosc. 2021 Aug;35(8):4528-4538. doi: 10.1007/s00464-020-07967-w. Epub 2020 Sep 9. PMID: 32909209..
186. Matsumoto K, Ueyama H, Yao T, Abe D, Oki S, Suzuki N, Ikeda A, Yatagai N, Akazawa Y, Komori H, Takeda T, Matsumoto K, Hojo M, Nagahara A. Diagnostic limitations of magnifying endoscopy with narrow-band imaging in early gastric cancer. Endosc Int Open. 2020 Oct;8(10):E1233-E1242. doi: 10.1055/a-1220-6389. Epub 2020 Sep 21. PMID: 33015324; PMCID: PMC7505700.
187. Murakami T, Nagahara A, Yao T. Rare case of colorectal traditional serrated adenoma mimicking a subepithelial lesion. Dig Endosc. 2021 Jan;33(1):208. doi: 10.1111/den.13872. Epub 2020 Nov 20. PMID: 33058274.
188. Takeda T, Asaoka D, Abe D, Suzuki M, Nakagawa Y, Sasaki H, Inami Y, Ikemura M, Utsunomiya H, Oki S, Suzuki N, Ikeda A, Yatagai N, Komori H, Akazawa Y, Matsumoto K, Ueda K, Ueyama H, Shimada Y, Matsumoto K, Hojo M, Osada T, Nojiri S, Nagahara A. Linked color imaging improves visibility of reflux esophagitis. BMC Gastroenterol. 2020 Oct 27;20(1):356. doi: 10.1186/s12876-020-01511-9. PMID: 33109095; PMCID: PMC7590454.
189. Asaoka D, Takeda T, Inami Y, Abe D, Shimada Y, Matsumoto K, Ueyama H, Matsumoto K, Komori H, Akazawa Y, Osada T, Hojo M, Nagahara A. Association between the severity of constipation and sarcopenia in elderly adults: A single-center university hospital-based, cross-sectional study. Biomed Rep. 2021 Jan;14(1):2. doi: 10.3892/br.2020.1378. Epub 2020 Oct 22. PMID: 33235719; PMCID: PMC7678610.
190. Hojo M, Asaoka D, Takeda T, Shimada Y, Matsumoto K, Matsumoto K, Yatagai N, Akazawa Y, Ueda K, Ueyama H, Nagahara A. Randomized controlled study on the effects of triple therapy including vonoprazan or rabeprazole for the second-line treatment of Helicobacter pylori infection. Therap Adv Gastroenterol. 2020 Nov 11;13:1756284820966247. doi: 10.1177/1756284820966247. PMID: 33240391; PMCID: PMC7675913.
191. Ogiwara S, Furihata M, Inami Y, Okawa H, Nomoto Y, Kitamura T, Osada T, Nagahara A. Does Endoscopic Retrograde Cholangiopancreatography Carry Higher Risk for Patients 90 Years and Older? A Single-Institution Retrospective Study. Med Sci Monit. 2020 Dec 7;26:e928033. doi: 10.12659/MSM.928033. PMID: 33281183; PMCID: PMC7731116.
192. Yatagai N, Ueyama H, Ikemura M, Uchida R, Utsunomiya H, Abe D, Oki S, Suzuki N, Ikeda A, Akazawa Y, Komori H, Takeda T, Matsumoto K, Ueda K, Matsumoto K, Asaoka D, Hojo M, Tsuyama S, Hayashi T, Yao T, Nagahara A. Clinicopathological and Endoscopic Features of Raspberry-Shaped Gastric Cancer in Helicobacter pylori-Uninfected Patients. Digestion. 2020 Dec 15:1-8. doi: 10.1159/000511907. Epub ahead of print. PMID: 33321493.
193. Kamiya T, Osaga S, Kubota E, Fukudo S, Motoya S, Murakami K, Nagahara A, Shiotani A, Sugimoto M, Suzuki H, Watanabe T, Yamaguchi S, Chan FKL, Hahm KB, Fock KM, Zhu Q; International Gastroenterology Consensus Symposium Study Group. Questionnaire-Based Survey on Epidemiology of Functional Gastrointestinal Disorders and Current Status of Gastrointestinal Motility Testing in Asian Countries. Digestion. 2020 Dec 16;102(1):73-89. doi: 10.1159/000513292. Epub ahead of print. PMID: 33326975.
194. Matsumoto K, Sakamoto N, Murakami T, Yatagai N, Tsuyama S, Fukushima H, Ueyama H, Shibuya T, Yao T, Nagahara A. Long-term relapse-free treatment with endoscopic submucosal dissection combined with magnifying narrow-band imaging for a pregnant patient with flat-type condyloma acuminatum: a case report. Clin J Gastroenterol. 2021 Apr;14(2):439-445. doi: 10.1007/s12328-020-01288-0. Epub 2021 Jan 4. PMID: 33394332.
195. Takasaki Y, Ishii S, Shibuya T, Fujisawa T, Ushio M, Takahashi S, Ito K, Yamagata W, Suzuki A, Okahara K, Okawa Y, Ochiai K, Tomishima K, Nomura O, Haga K, Saito H, Nagahara A, Isayama H. Endoscopic ultrasound-guided antegrade procedures for managing bile duct stones in patients with surgically altered anatomy: Comparison with double-balloon enteroscopy-assisted endoscopic retrograde cholangiography (with video). Dig Endosc. 2021 Nov;33(7):1179-1187. doi: 10.1111/den.13927. Epub 2021 Feb 9. PMID: 33421211.
196. Ueyama H, Murakami T, Matsumoto K, Sakamoto N, Osada T, Yao T, Nagahara A.　Modified attachment method using S-O clip and multibending scope for gastric ESD　at the greater curvature of the fundus. Endosc Int Open. 2021　Feb;9(2):E195-E196. doi: 10.1055/a-1315-0293. Epub 2021 Jan 25. PMID: 33532558; PMCID: PMC7834921.
197. Ueyama H, Yatagai N, Ikeda A, Akazawa Y, Komori H, Takeda T, Matsumoto K, Ueda K, Matsumoto K, Asaoka D, Hojo M, Yao T, Nagahara A. Dynamic diagnosis of early gastric cancer with microvascular blood flow rate using magnifying endoscopy (with video): A pilot study. J Gastroenterol Hepatol. 2021 Jul;36(7):1927-1934. doi: 10.1111/jgh.15425. Epub 2021 Feb 22. PMID: 33533505; PMCID: PMC8359341.
198. Fukuo Y, Shibuya T, Ashizawa K, Ito K, Saeki M, Fukushima H, Takahashi M, Nomura K, Okahara K, Haga K, Akazawa Y, Nomura O, Ogura K, Okubo H, Nagahara A. Plasmablastic Lymphoma of the Small Intestine in an HIV- and EBV-negative Patient. Intern Med. 2021 Sep 15;60(18):2947-2952. doi: 10.2169/internalmedicine.6837-20. Epub 2021 Mar 29. PMID: 33776007; PMCID: PMC8502670.
199. Nomura K, Ishikawa D, Okahara K, Ito S, Haga K, Takahashi M, Arakawa A, Shibuya T, Osada T, Kuwahara-Arai K, Kirikae T, Nagahara A. Bacteroidetes Species Are Correlated with Disease Activity in Ulcerative Colitis. J Clin Med. 2021 Apr 17;10(8):1749. doi: 10.3390/jcm10081749. PMID: 33920646; PMCID: PMC8073534.
200. Haraikawa M, Kudo H, Shibuya T, Kogure Y, Takase M, Inage H, Yokota T, Htun H, Tagaya E, Fan R, Houshito H, Taniguchi G, Sakamoto K, Nagahara A. Efficacy of CO₂ Infusion for Preoperative Computed Tomographic Angiography with Computed Tomographic Colonography. Med Sci Monit. 2021 May 16;27:e931055. doi: 10.12659/MSM.931055. PMID: 33993185; PMCID: PMC8135977.
201. Tomishima K, Ishii S, Fujisawa T, Ikemura M, Ushio M, Takahashi S, Yamagata W, Takasaki Y, Suzuki A, Ito K, Haga K, Ochiai K, Nomura O, Saito H, Shibuya T, Nagahara A, Isayama H. Evaluation of the Feasibility and Effectiveness of Placement of Fully Covered Self-Expandable Metallic Stents via Various Insertion Routes for Benign Biliary Strictures. J Clin Med. 2021 May 28;10(11):2397. doi: 10.3390/jcm10112397. PMID: 34071678; PMCID: PMC8198386.
202. Tomishima K, Ishii S, Fujisawa T, Yatagai N, Kabemura D, Sato S, Amano N, Murata A, Tsuzura H, Sato S, Matsumoto K, Shimada Y, Genda T, Nagahara A, Isayama H. Does restricting fluid volume impact post-ERCP pancreatitis in patient with heart disease? Saudi J Gastroenterol. 2021 Nov-Dec;27(6):355-360.doi: 10.4103/sjg.sjg_693_20. PMID: 34213425; PMCID: PMC8656333.
203. Shibuya T, Nomura O, Nagahara A. Safety and Efficacy of Ustekinumab for Ulcerative Colitis in a Liver Transplant Patient. Inflamm Bowel Dis. 2021 Nov 15;27(12):e150-e151. doi: 10.1093/ibd/izab169. PMID: 34255040.
204. Ueyama H, Yao T, Akazawa Y, Hayashi T, Kurahara K, Oshiro Y, Yamada M, Oda I, Fujioka S, Kusumoto C, Fukuda M, Uchita K, Kadota T, Oono Y, Okamoto K, Murakami K, Matsuo Y, Kato M, Maehata T, Yahagi N, Yasuhara Y, Yada T, Uraushihara K, Yamane T, Matsuo T, Ito M, Maruyama Y, Osako A, Ono S, Kato M, Yagi K, Hashimoto T, Tomita N, Tsuyama S, Saito T, Matsumoto K, Matsumoto K, Watanabe S, Uemura N, Chiba T, Nagahara A. Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type. J Gastroenterol. 2021 Sep;56(9):814-828. doi: 10.1007/s00535-021-01813-z. Epub 2021 Jul 15. PMID: 34268625; PMCID: PMC8370942.
205. Fukushima H, Sakamoto N, Shibuya T, Haga K, Nomura O, Murakami T, Ueyama H, Ishikawa D, Hojo M, Nagahara A. A Comparative Study of Early Mucosal Healing Following Hot Polypectomy and Cold Polypectomy. Med Sci Monit. 2021 Aug 25;27:e933043. doi: 10.12659/MSM.933043. PMID: 34432770; PMCID: PMC8404476.
206. Tomishima K, Ishii S, Fujisawa T, Ikemura M, Ota H, Kabemura D, Ushio M, Fukuma T, Takahashi S, Yamagata W, Takasaki Y, Suzuki A, Ito K, Saito H, Nagahara A, Isayama H. Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer. Cancers (Basel). 2021 Aug 22;13(16):4224. doi: 10.3390/cancers13164224. PMID: 34439377; PMCID: PMC8391823.
207. Yasutomi Y, Chiba A, Haga K, Murayama G, Makiyama A, Kuga T, Watanabe M, Okamoto R, Nagahara A, Nagaishi T, Miyake S. Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel Disease. Cell Mol Gastroenterol Hepatol. 2022;13(1):81-93. doi: 10.1016/j.jcmgh.2021.08.018. Epub 2021 Aug 28. PMID: 34461283; PMCID: PMC8593615.
208. Takeda T, Ueyama H, Fu KI, Murata S, Nagahara A. Minute gastric adenocarcinoma of the fundic-gland type with submucosal invasion. Endoscopy. 2021 Sep 27. doi: 10.1055/a-1625-5865. Epub ahead of print. PMID: 34571564.
209. Ikemura M, Tomishima K, Ushio M, Takahashi S, Yamagata W, Takasaki Y, Suzuki A, Ito K, Ochiai K, Ishii S, Saito H, Fujisawa T, Nagahara A, Isayama H. Impact of the Coronavirus Disease-2019 Pandemic on Pancreaticobiliary Disease Detection and Treatment. J Clin Med. 2021 Sep 16;10(18):4177. doi: 10.3390/jcm10184177. PMID: 34575288; PMCID: PMC8470255.
210. Fukushima H, Murakami T, Suzuki N, Shibuya T, Yao T, Nagahara A. Rare case of advanced rectal cancer with multiple liver and bone metastases presenting with McKittrick-Wheelock syndrome. JGH Open. 2021 Aug 11;5(9):1103-1105. doi: 10.1002/jgh3.12635. PMID: 34584983; PMCID: PMC8454474.
211. Haga K, Shibuya T, Nomura K, Haraikawa M, Nomura O, Nagahara A. Jejunostomy tube removed after pancreaticoduodenectomy using single-balloon endoscopy. Endoscopy. 2021 Oct 1. doi: 10.1055/a-1630-6122. Epub ahead of print. PMID: 34598284.
212. Hojo M, Nagahara A, Kudo T, Takeda T, Ikuse T, Matsumoto K, Ueda K, Ueyama　H, Matsumoto K, Asaoka D, Shimizu T. Endoscopic findings of Helicobacter pylori gastritis in children and young adults based on the Kyoto classification of gastritis and age-associated changes. JGH Open. 2021 Aug 27;5(10):1197-1202. doi: 10.1002/jgh3.12652. PMID: 34622008; PMCID: PMC8485397.
213. Maruyama T, Murakami T, Akazawa Y, Shibuya T, Nagahara A. A case of improved visibility with gel immersion in the presence of ongoing bleeding during colorectal endoscopic submucosal dissection. VideoGIE. 2021 Jul 23;6(10):478-480. doi: 10.1016/j.vgie.2021.06.009. PMID: 34667916; PMCID: PMC8504151.
214. Fukushima H, Shibuya T, Awatsu T, Kurosawa T, Haga K, Murakami T, Serizawa N, Mori A, Hojo M, Yao T, Hattori N, Nagahara A. CV2/CRMP5-antibody-related Paraneoplastic Neurologic Syndrome Associated with Gastrointestinal Stromal Tumor. Intern Med. 2021 Oct 19. doi: 10.2169/internalmedicine.8425-21. Epub ahead of print. PMID: 34670904.
215. Otani K, Watanabe T, Higashimori A, Suzuki H, Kamiya T, Shiotani A, Sugimoto M, Nagahara A, Fukudo S, Motoya S, Yamaguchi S, Zhu Q, Chan FKL, Hahm KB, Tablante MC, Prachayakul V, Abdullah M, Ang TL, Murakami K; International Gastrointestinal Consensus Symposium Study Group. A Questionnaire-Based Survey on the Impact of the COVID-19 Pandemic on Gastrointestinal Endoscopy in Asia. Digestion. 2022;103(1):7-21. doi: 10.1159/000520287. Epub 2021 Nov 10. PMID: 34758472; PMCID: PMC8678234.
216. Kamba E, Murakami T, Nagahara A. Complete disappearance of a large pedunculated polyp. Dig Endosc. 2021 Nov 22. doi: 10.1111/den.14198. Epub ahead of print. PMID: 34807479.
217. Ueyama H, Akazawa Y, Fujisawa T, Isayama H, Nagahara A. A novel endoscopic shield: a barrier device to minimize virus transmission during endoscopy. Endoscopy. 2021 Dec 15. doi: 10.1055/a-1695-3080. Epub ahead of print. PMID: 34911117.
218. Hojo M, Ueda K, Takeda T, Akazawa Y, Ueyama H, Shimada Y, Asaoka D, Nagahara A. The relationship between Helicobacter pylori infection and reflux esophagitis and the long-term effects of eradication of Helicobacter pylori on reflux esophagitis. Therap Adv Gastroenterol. 2021 Dec 9;14:17562848211059942. doi: 10.1177/17562848211059942. PMID: 34917172; PMCID: PMC8669870.
219. Okubo H, Ando H, Ishizuka K, Morishige JI, Ikejima K, Shiina S, Nagahara A. Impact of genetic polymorphisms on the pharmacokinetics and pharmacodynamics of lenvatinib in patients with hepatocellular carcinoma. J Pharmacol Sci. 2022 Jan;148(1):6-13. doi: 10.1016/j.jphs.2021.08.011. Epub 2021 Sep 1. PMID: 34924131.
220. Okubo H, Ando H, Nakadera E, Ikejima K, Shiina S, Nagahara A. Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis. Nutrients. 2021 Dec 10;13(12):4428. doi: 10.3390/nu13124428. PMID: 34959980; PMCID: PMC8705344.
221. Nakajima A, Shibuya T, Sasaki T, Lu YJ, Ishikawa D, Haga K, Takahashi M, Kaga N, Osada T, Sato N, Nagahara A. Nicotine Oral Administration Attenuates DSS-Induced Colitis Through Upregulation of Indole in the Distal Colon and Rectum in Mice. Front Med (Lausanne). 2021 Dec 13;8:789037. doi: 10.3389/fmed.2021.789037. PMID: 34966763; PMCID: PMC8710606.
222. Hojo M, Asaoka D, Shimada Y, Nojiri S, Nagahara A. Strategies for discontinuation of proton pump inhibitors (PPIs) in patients with long-term PPI administration: a randomized controlled trial. BMC Gastroenterol. 2022 Jan 15;22(1):21. doi: 10.1186/s12876-021-02086-9. PMID: 35033011; PMCID: PMC8760744.
223. Hagiwara T, Sugimoto K, Momose H, Irie T, Honjo K, Okazawa YU, Kawai M, Kawano S, Munakata S, Takahashi M, Kojima Y, Serizawa N, Nagahara A, Hoffman RM, Brock MV, Sakamoto K. CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal Cancer. Anticancer Res. 2022 Feb;42(2):697-707. doi: 10.21873/anticanres.15528. PMID: 35093868.
224. Zhang X, Ishikawa D, Nomura K, Fukuda N, Haraikawa M, Haga K, Shibuya T, Mita T, Nagahara A. Donor Screening Revisions of Fecal Microbiota Transplantation in Patients with Ulcerative Colitis. J Clin Med. 2022 Feb 17;11(4):1055. doi: 10.3390/jcm11041055. PMID: 35207328; PMCID: PMC8879222.
225. Shibuya T, Nomura O, Nomura K, Haraikawa M, Haga K, Ishikawa D, Osada T, Yamaji K, Ikeda S, Nagahara A. Efficacy of cytapheresis for induction therapy and extra-intestinal skin manifestations of ulcerative colitis. Ther Apher Dial. 2022 Mar 5. doi: 10.1111/1744-9987.13823. Epub ahead of print. PMID: 35247233
226. Fujisawa T, Fukuda H, Sakamoto N, Hojo M, Tomishima K, Ishii S, Yokokawa H, Saita M, Naito T, Nagahara A, Watanabe S, Isayama H. Relief Effect of Carbon Dioxide Insufflation in Transnasal Endoscopy for Health Checks-A Prospective, Double-Blind, Case-Control Trial. J Clin Med. 2022 Feb 24;11(5):1231. doi: 10.3390/jcm11051231. PMID: 35268322; PMCID: PMC8911034.
227. Ishikawa D, Zhang X, Nomura K, Seki N, Haraikawa M, Haga K, Shibuya T, Kim YG, Nagahara A. A Randomized Placebo-Controlled Trial of Combination Therapy With Post-triple-antibiotic-therapy Fecal Microbiota Transplantation and Alginate for Ulcerative Colitis: Protocol. Front Med (Lausanne). 2022 Feb 22;9:779205. doi: 10.3389/fmed.2022.779205. PMID: 35273972; PMCID: PMC8902497.
228. Okano S, Yao T, Nomura O, Nagahara A, Hagiwara T, Sugimoto K, Takahashi M, Sakamoto K. Enterocolic Lymphocytic Phlebitis Treated Preoperatively with Biologics and Immunosuppressive Agents. Case Rep Pathol. 2022 Mar 7;2022:5120607. doi: 10.1155/2022/5120607. PMID: 35295675; PMCID: PMC8920688.
229. Kurosawa T, Murakami T, Yamashiro Y, Terukina H, Hayashi T, Saito T, Nojiri S, Sakamoto K, Nagahara A, Yao T. Mucin phenotypes and clinicopathological features of colorectal adenocarcinomas: Correlation with colorectal adenocarcinoma with enteroblastic differentiation. Pathol Res Pract. 2022 Apr;232:153840. doi: 10.1016/j.prp.2022.153840. Epub 2022 Mar 10. PMID: 35303523.
230. Murakami T, Kurosawa T, Fukushima H, Shibuya T, Yao T, Nagahara A. Sessile serrated lesions: Clinicopathological characteristics, endoscopic diagnosis, and management. Dig Endosc. 2022 Mar 29. doi: 10.1111/den.14273. Epub ahead of print. PMID: 35352394.
231. Hakoda A, Takeuchi T, Kojima Y, Fujiwara Y, Nagami Y, Naito Y, Fukuda S, Koike T, Sugimoto M, Hamada K, Kobara H, Yoshida N, Inaba T, Nagahara A, Koizumi E, Murakami K, Furuta T, Ogasawara N, Isomoto H, Shibagaki K, Kataoka H, Suzuki H, Higuchi K. Risk factors and prediction of bleeding after gastric endoscopic submucosal dissection in patients on antithrombotic therapy: newly developed bleeding prediction application software, SAMURAI model. J Clin Biochem Nutr. 2022 Mar;70(2):189-196. doi: 10.3164/jcbn.21-136. Epub 2021 Dec 3. PMID: 35400818; PMCID: PMC8921730.
232. Murakami T, Yao T, Nagahara A. A rare case of early colonic cancer showing diverticulum-like morphology. Dig Endosc. 2022 Apr 12. doi: 10.1111/den.14326. Epub ahead of print. PMID: 35411568.
233. Okubo H, Atsukawa M, Okubo T, Ando H, Nakadera E, Ikejima K, Nagahara A. Gadoxetic acid-enhanced magnetic resonance imaging predicts hyperbilirubinemia induced by glecaprevir during hepatitis C virus treatment. Sci Rep. 2022 May 12;12(1):7847. doi: 10.1038/s41598-022-11707-6. PMID: 35552472; PMCID: PMC9098462.
234. Taniguchi G, Kajino K, Momose S, Saeki H, Yue L, Ohtsuji N, Abe M, Shibuya T, Orimo A, Nagahara A, Watanabe S, Hino O. The Inhibitory Effects of Anti-ERC/Mesothelin Antibody 22A31 on Colorectal Adenocarcinoma Cells, within a Mouse Xenograft Model. Cancers (Basel). 2022 Apr 28;14(9):2198. doi: 10.3390/cancers14092198. PMID: 35565327.

研究者

教育活動

【学校法人順天堂】研究者情報データベース

研究業績詳細

永原 章仁（ナガハラ アキヒト）

永原章仁（ナガハラアキヒト）